var title_f38_48_39680="Link disease gene location";
var content_f38_48_39680=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F57437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F57437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 552px\">",
"   <div class=\"ttl\">",
"    Linkage to resolve location of disease gene",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 532px; height: 290px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    With successive meioses, recombination narrows chromosomal region harboring disease locus (+).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39680=[""].join("\n");
var outline_f38_48_39680=null;
var title_f38_48_39681="Estimating pessary size";
var content_f38_48_39681=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F74477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F74477&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Estimating size of vaginal pessary required",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) A bimanual examination is performed to judge the distance from the posterior fornix to the posterior pubic symphysis. (B) The spot where the pubic symphysis rests on the examining hand is mentally marked. Sample pessaries are then held up to the examining hand to estimate the proper pessary size.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39681=[""].join("\n");
var outline_f38_48_39681=null;
var title_f38_48_39682="Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents";
var content_f38_48_39682=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/48/39682/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39682/contributors\">",
"     Lloyd Axelrod, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/48/39682/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39682/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/48/39682/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39682/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/48/39682/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     CASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 61-year-old restaurant manager with type 2 diabetes returns for a routine office visit. Diabetes was discovered nine years ago on routine examination by his previous clinician when a random blood glucose was 193",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (10.7",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    The A1C was 8.6 percent. The patient was treated initially with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/6/29800?source=see_link\">",
"     glyburide",
"    </a>",
"    5 mg every morning before breakfast.",
"   </p>",
"   <p>",
"    Over the next two years, the dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/6/29800?source=see_link\">",
"     glyburide",
"    </a>",
"    was increased incrementally to a dose of 10 mg twice daily before breakfast and supper. The blood glucose values improved and the A1C fell to the 7.3 to 7.8 percent range, the level depending for the most part on dietary adherence.",
"   </p>",
"   <p>",
"    Three years ago the A1C level rose to 8.4 percent and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    was added. The initial dose of 500 mg twice a day with meals was increased rapidly to 1000 mg twice a day. The A1C fell to the 7.2 to 7.7 percent range.",
"   </p>",
"   <p>",
"    You saw the patient for the first time one year ago. The A1C was 7.8 percent and you suggested the need for additional medication to reduce the A1C value to &lt;7.0 percent. The patient was reluctant to take another medication and said he would improve his diet. There is a buffet in the restaurant where he worked. Although he was eating three modest meals a day, he was nibbling constantly from about 4 pm until after midnight on crackers, peanuts, sausage, and cheese. He promised to limit himself to a modest snack at the end of each evening. The patient did not return during the intervening year but does so now because his blood glucose values have been rising despite his \"improved\" diet.",
"   </p>",
"   <p>",
"    At the present time, the patient reports that he is no longer working in the restaurant and is following his diet. Breakfast is now two slices of whole grain bread and cappuccino. Lunch is a steak and a salad. Supper is often veal parmesan and a salad. He is no longer nibbling in the evening but does have a bedtime snack. He is pleased with his improved diet, notes that it has been a difficult transition, and is unwilling to make further changes.",
"   </p>",
"   <p>",
"    He purchased an elliptical cross-trainer two months ago but has used it only three times. He did not bring his glucose diary but reports that his fasting blood glucose values at home are in the 150 to 165",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (8.3 to 9.2",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    range with no tests later in the day. He notes an increased frequency of urination, attributed to drinking three beers a day.",
"   </p>",
"   <p>",
"    On examination, the blood pressure is",
"    <span class=\"nowrap\">",
"     130/70",
"    </span>",
"    supine and",
"    <span class=\"nowrap\">",
"     140/80",
"    </span>",
"    upright, the heart rate is",
"    <span class=\"nowrap\">",
"     72/minute,",
"    </span>",
"    regular. His weight is 227 lbs; the BMI is 33.5",
"    <span class=\"nowrap\">",
"     kg/m(2).",
"    </span>",
"    Funduscopic examination reveals no evidence of retinopathy. The mucous membranes are moist. Examination of the chest, heart, and abdomen reveals no abnormality. The dorsal pedal and posterior tibial pulses are present. There is no edema. The feet exhibit mild cock-up deformities of the toes of both feet, and a callus beneath the right first metatarsal-phalangeal joint. Light touch sensation is moderately reduced to the level of the distal calves. Vibration sensation is moderately reduced at the great toes and medial malleoli, and mildly reduced at the tibial tubercles. The deep tendon reflexes are absent in all extremities.",
"   </p>",
"   <p>",
"    The patient's current medications are",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    1000 mg twice daily,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/6/29800?source=see_link\">",
"     glyburide",
"    </a>",
"    10 mg twice daily,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/58/937?source=see_link\">",
"     lisinopril",
"    </a>",
"    10 mg every morning,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/27/25016?source=see_link\">",
"     pravastatin",
"    </a>",
"    40 mg daily at bedtime,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    81 mg daily, a multivitamin once daily and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/4/19528?source=see_link\">",
"     tadalafil",
"    </a>",
"    10 mg daily as needed.",
"   </p>",
"   <p>",
"    Fasting laboratory studies reveal the following: glucose 220",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (12.2",
"    <span class=\"nowrap\">",
"     mmol/L);",
"    </span>",
"    sodium 141, potassium 4.6, chloride 102 and carbon dioxide 27",
"    <span class=\"nowrap\">",
"     meq/L;",
"    </span>",
"    triglycerides 110",
"    <span class=\"nowrap\">",
"     mg/dl",
"    </span>",
"    (1.2",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    total cholesterol 169",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (4.4",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    HDL cholesterol 40",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.0",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and LDL cholesterol 107",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.8",
"    <span class=\"nowrap\">",
"     mmol/L);",
"    </span>",
"    A1C 9.2 percent. The urinary",
"    <span class=\"nowrap\">",
"     microalbumin/creatinine",
"    </span>",
"    ratio is within normal limits.",
"   </p>",
"   <p>",
"    You conclude that the patient has not been in acceptable metabolic control for years, based on the A1c values, and is now uncontrolled on full doses of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/6/29800?source=see_link\">",
"     glyburide",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    You encourage him to continue his diet and to increase his exercise, either by using the elliptical cross-trainer or by walking 30 to 35 minutes five to seven days a week.",
"   </p>",
"   <p>",
"    You note that the LDL cholesterol is above the target value for a patient with diabetes and multiple other cardiovascular risk factors. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3002?source=see_link\">",
"     \"Intensity of lipid lowering therapy in secondary prevention of coronary heart disease\"",
"    </a>",
"    .) You increase the dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/27/25016?source=see_link\">",
"     pravastatin",
"    </a>",
"    to 60 mg daily at bedtime.",
"   </p>",
"   <p>",
"    You advise the patient to start an additional diabetes medication. Which additional medication do you add to the patient's current regimen?",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/28/43463?source=see_link\">",
"       Pioglitazone",
"      </a>",
"      15 mg po daily every morning. (See",
"      <a class=\"medical medical_answer\" href=\"mobipreview.htm?38/48/39682-a1?source=see_link\">",
"       \"Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents - A1\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/2/14375?source=see_link\">",
"       Exenatide",
"      </a>",
"      (Byetta) 5 micrograms subcutaneously twice a day before breakfast and supper. You schedule an appointment with the certified diabetes educator in your practice to instruct the patient in the technique of subcutaneous injection and in the use of this agent. (See",
"      <a class=\"medical medical_answer\" href=\"mobipreview.htm?38/48/39682-a2?source=see_link\">",
"       \"Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents - A2\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?5/31/5622?source=see_link\">",
"       Sitagliptin",
"      </a>",
"      (Januvia) 100 mg po daily every morning. (See",
"      <a class=\"medical medical_answer\" href=\"mobipreview.htm?38/48/39682-a3?source=see_link\">",
"       \"Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents - A3\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?13/22/13669?source=see_link\">",
"       Pramlintide",
"      </a>",
"      (Symlin) 60 micrograms subcutaneously three times a day before meals. You schedule an appointment with the certified diabetes educator in your practice to instruct the patient in the technique of subcutaneous injection and in the use of this agent. (See",
"      <a class=\"medical medical_answer\" href=\"mobipreview.htm?38/48/39682-a4?source=see_link\">",
"       \"Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents - A4\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Glargine (Lantus) insulin 20 units at bedtime (approximately 0.2 units per kilogram) as the initial dose. You schedule an appointment with the certified diabetes educator in your practice to instruct the patient in the technique of subcutaneous injection and in the use of insulin. (See",
"      <a class=\"medical medical_answer\" href=\"mobipreview.htm?38/48/39682-a5?source=see_link\">",
"       \"Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents - A5\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4176 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-217.117.136.88-59DAAF2E3B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39682=[""].join("\n");
var outline_f38_48_39682=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      CASE",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3002?source=related_link\">",
"      Intensity of lipid lowering therapy in secondary prevention of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"mobipreview.htm?38/48/39682-a1?source=related_link\">",
"      Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents - A1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"mobipreview.htm?38/48/39682-a2?source=related_link\">",
"      Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents - A2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"mobipreview.htm?38/48/39682-a3?source=related_link\">",
"      Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents - A3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"mobipreview.htm?38/48/39682-a4?source=related_link\">",
"      Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents - A4",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"mobipreview.htm?38/48/39682-a5?source=related_link\">",
"      Interactive diabetes case 16: A 61-year-old man with uncontrolled type 2 diabetes on two oral agents - A5",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_48_39683="Lap hernia still C";
var content_f38_48_39683=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F57923&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F57923&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lap hernia still C",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 416px; height: 338px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39683=[""].join("\n");
var outline_f38_48_39683=null;
var title_f38_48_39684="Loteprednol: Drug information";
var content_f38_48_39684=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Loteprednol: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/58/20388?source=see_link\">",
"    see \"Loteprednol: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F190305\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alrex&reg;;",
"     </li>",
"     <li>",
"      Lotemax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F190306\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Alrex&reg;;",
"     </li>",
"     <li>",
"      Lotemax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F190318\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Corticosteroid, Ophthalmic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F190307\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Seasonal allergic conjunctivitis:",
"     </b>",
"     Ophthalmic: Alrex&reg; 0.2% suspension: Instill 1 drop into affected eye(s) 4 times daily.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Inflammatory conditions:",
"     </b>",
"     Ophthalmic: Lotemax&reg; 0.5% suspension: Instill 1-2 drops into the conjunctival sac of the affected eye(s) 4 times daily. During the initial treatment within the first week, the dosing may be increased up to 1 drop every hour. Advise patients not to discontinue therapy prematurely. If signs and symptoms fail to improve after 2 days, re-evaluate the patient.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Postoperative inflammation:",
"     </b>",
"     Ophthalmic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lotemax&reg; 0.5% ointment: Apply ~",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     inch ribbon into the conjunctival sac of the affected eye(s) 4 times daily beginning 24 hours after surgery and continuing throughout the first 2 weeks of the postoperative period.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lotemax&reg; 0.5% gel, 0.5% suspension: Instill 1-2 drops into the conjunctival sac of the affected eye(s) 4 times daily beginning 24 hours after surgery and continuing throughout the first 2 weeks of the postoperative period.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F190308\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F16265710\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling. However, dosage adjustment unlikely due to low systemic absorption.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F16265711\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling. However, dosage adjustment unlikely due to low systemic absorption.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F190295\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, ophthalmic, as etabonate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lotemax&reg;: 0.5% (5 g) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, ophthalmic, as etabonate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lotemax&reg;: 0.5% (3.5 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suspension, ophthalmic, as etabonate [drops]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Alrex&reg;: 0.2% (5 mL, 10 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lotemax&reg;: 0.5% (5 mL, 10 mL, 15 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F190283\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F190297\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gel: While bottle is closed, invert and shake once to fill tip prior to instilling drops.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Suspension: Shake well before using.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F190296\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Alrex&reg;: Temporary relief of signs and symptoms of seasonal allergic conjunctivitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lotemax&reg;: Treatment of postoperative inflammation and pain following ocular surgery; treatment of inflammatory conditions (eg, steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F190316\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (2% to &lt;15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Anterior chamber inflammation (5% to 25%), abnormal vision/blurring (5% to 15%), burning on instillation (5% to 15%), chemosis (5% to 15%), discharge (5% to 15%), dry eyes (5% to 15%), epiphora (5% to 15%), foreign body sensation (2% to 15%), itching (5% to 15%), photophobia (5% to 15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Pharyngitis (&lt;15%), rhinitis (&lt;15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 5%: Ocular: Conjunctival hyperemia, conjunctivitis/irritation, corneal abnormalities, corneal edema, eyelid erythema, increased intraocular pressure, pain, papillae, uveitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Cataract formation, changes in visual acuity and/or field defects, global perforation in disease which thins cornea or sclera, optic nerve damage, secondary ocular infection",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F190300\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to loteprednol, other corticosteroids, and any component of the formulation; viral diseases of the cornea and conjunctiva (including epithelial herpes simplex keratitis, vaccinia, and varicella); mycobacterial infection of the eye; fungal diseases of ocular structures",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F190287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Immunosuppression: Prolonged use of corticosteroids (including ophthalmic preparations) may increase the incidence of secondary infection, mask acute infection (including fungal infections), or prolong or exacerbate viral infections. Corticosteroids should not be used to treat ocular herpes simplex; use caution in patients with a history of ocular herpes simplex. Fungal infection should be suspected in any patient with persistent corneal ulceration who has received corticosteroids.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular effects: Prolonged use may result in glaucoma and injury to the optic nerve. Visual defects in acuity and field of vision may occur. Posterior subcapsular cataracts may form after long-term use. Use with caution in presence of glaucoma (steroids increase intraocular pressure). Perforation may occur with topical steroids in diseases which thin the cornea or sclera. Steroid use may delay healing after cataract surgery. Intraocular pressure should be monitored if this product is used &gt;10 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Contact lens wearers: Some preparations contain benzalkonium chloride which may be absorbed by contact lenses. When used for the treatment of seasonal allergic conjunctivitis, wait &ge;10 minutes after instilling eye drops before inserting contact lenses; do not wear contacts if eyes are red. Contact lenses should not be worn during treatment following ophthalmic surgery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Do not use ointment in children following ocular surgery; may interfere with amblyopia treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Acute anterior uveitis: More potent steroids may be required for this indication.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For ophthalmic use only; patients should be re-evaluated if symptoms fail to improve after 2 days. Initial prescription and renewal of medication should be made by healthcare provider only after examination with the aid of magnification such as slit lamp biomicroscopy or fluorescein staining (if appropriate). Avoid contamination; do not touch tip of applicator or let tip of applicator touch eye.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299617\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6221369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F190291\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13228758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Loteprednol was shown to be teratogenic in animal reproduction studies when administered orally. The amount of loteprednol absorbed systemically following ophthalmic administration is not known but expected to be &lt;1 ng/mL.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F190310\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F190301\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Gel",
"     </b>",
"     (Lotemax Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.5% (5 g): $146.44",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Ointment",
"     </b>",
"     (Lotemax Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.5% (3.5 g): $188.95",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Alrex Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.2% (5 mL): $155.14",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Lotemax Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.5% (10 mL): $292.87",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F190293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Intraocular pressure (if &gt;10 days); signs and symptoms of infection",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F190302\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Alrex (BR, HK);",
"     </li>",
"     <li>",
"      Lotemax (AR, GB, GR, HK, IE, IL, IT, MY, PL, SG, TH, TR, UY);",
"     </li>",
"     <li>",
"      Lotepred (IN);",
"     </li>",
"     <li>",
"      Loterex (MX);",
"     </li>",
"     <li>",
"      Lotesoft (PY, VE);",
"     </li>",
"     <li>",
"      Oftol (CN);",
"     </li>",
"     <li>",
"      Oftol Forte (EC)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F190286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Corticosteroids inhibit the inflammatory response including edema, capillary dilation, leukocyte migration, and scar formation. Loteprednol is highly lipid soluble and penetrates cells readily to induce the production of lipocortins. These proteins modulate the activity of prostaglandins and leukotrienes.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F190299\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action: Seasonal allergic conjunctivitis: Reduction of symptoms seen within 2 hours of instillation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Minimal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Metabolized to inactive carboxylic acid metabolites",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10116 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-08F90C6EF9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39684=[""].join("\n");
var outline_f38_48_39684=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190305\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190306\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190318\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190307\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190308\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16265710\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16265711\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190295\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190283\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190297\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190296\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190316\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190300\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190287\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299617\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6221369\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190291\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13228758\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190310\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190301\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190293\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190302\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190286\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F190299\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10116\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10116|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/58/20388?source=related_link\">",
"      Loteprednol: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_48_39685="Calcium acetate: Drug information";
var content_f38_48_39685=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Calcium acetate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?7/38/7780?source=see_link\">",
"    see \"Calcium acetate: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?20/51/21301?source=see_link\">",
"    see \"Calcium acetate: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F144308\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Eliphos&trade;;",
"     </li>",
"     <li>",
"      PhosLo&reg;;",
"     </li>",
"     <li>",
"      Phoslyra&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F4663225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      PhosLo&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F144324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidote;",
"     </li>",
"     <li>",
"      Calcium Salt;",
"     </li>",
"     <li>",
"      Phosphate Binder",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F144311\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Control of hyperphosphatemia (ESRD, on dialysis):",
"     </b>",
"     Oral: Initial: 1334 mg with each meal, can be increased gradually (ie, every 2-3 weeks) to bring the serum phosphate value &lt;6 mg/dL as long as hypercalcemia does not develop (usual dose: 2001-2668 mg calcium acetate with each meal); do not give additional calcium supplements",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F12769425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15682399\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15682400\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F144293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gelcap, oral: 667 mg [equivalent to elemental calcium 169 mg (8.45 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     PhosLo&reg;: 667 mg [equivalent to elemental calcium 169 mg (8.45 mEq)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Phoslyra&trade;: 667 mg/5 mL (473 mL) [contains maltitol (1 g/5 mL), propylene glycol; black cherry-menthol flavor; equivalent to elemental calcium 169 mg (8.45 mEq)/5 mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Eliphos&trade;: 667 mg [equivalent to elemental calcium 169 mg (8.45 mEq)]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F144278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Gelcap",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F144296\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer with meals.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F144295\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Control of hyperphosphatemia in end-stage renal failure; does not promote aluminum absorption",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F144331\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       PhosLo&reg; may be confused with Phos-Flur&reg;, ProSom",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F144322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Hypercalcemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Diarrhea (oral solution)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%: Gastrointestinal: Nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Dizziness, edema, pruritus, weakness",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F144299\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to any component of the formulation; hypercalcemia, renal calculi",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F144282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal effects: Constipation, bloating, and gas are common with calcium supplements (especially carbonate salt).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypercalcemia: Mild-to-severe hypercalcemia may occur; decrease calcium acetate dose or temporarily discontinue, depending on severity of hypercalcemia; in addition, decrease or discontinue any concomitant vitamin D therapy. Chronic hypercalcemia may result in vascular calcification and other soft-tissue calcification.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Arrhythmias: Use with caution in patients who may be at risk of cardiac arrhythmias.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypoparathyroid disease: Hypercalcemia and hypercalciuria are most likely to occur in hypoparathyroid patients receiving high doses of vitamin D.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Digitalis: Use with caution in digitalized patients; hypercalcemia may precipitate cardiac arrhythmias.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Minerals/other oral drugs: Calcium administration interferes with absorption of some minerals and drugs; use with caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Maltitol: Oral solution may contain maltitol (a sugar substitute) which may cause a laxative effect.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298930\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F144287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Calcium Salts may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of oral calcium supplements within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Pamidronate; Zoledronic Acid.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers: Calcium Salts may diminish the therapeutic effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: May enhance the adverse/toxic effect of Calcium Acetate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CefTRIAXone: Calcium Salts (Intravenous) may enhance the adverse/toxic effect of CefTRIAXone. Ceftriaxone binds to calcium forming an insoluble precipitate.  Management: Use of ceftriaxone with calcium-containing solutions within 48 hours of one another is contraindicated in neonates (28 days of age or younger).  In older patients, flush lines with compatible fluid between administration.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferiprone: Calcium Salts may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DOBUTamine: Calcium Salts may diminish the therapeutic effect of DOBUTamine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eltrombopag: Calcium Salts may decrease the serum concentration of Eltrombopag.  Management: Separate administration of eltrombopag and any polyvalent cation (e.g., calcium-containing products) by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Estramustine: Calcium Salts may decrease the absorption of Estramustine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May increase the serum concentration of Calcium Salts.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphate Supplements: Calcium Salts may decrease the absorption of Phosphate Supplements.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Potassium Phosphate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Calcium Salts may decrease the absorption of Quinolone Antibiotics. Of concern only with oral administration of both agents.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Moxifloxacin (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Strontium Ranelate: Calcium Salts may decrease the serum concentration of Strontium Ranelate.  Management: Separate administration of strontium ranelate and oral calcium salts by at least 2 hours in order to minimize this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: Calcium Salts may decrease the serum concentration of Tetracycline Derivatives.  Management: If coadministration of oral calcium with oral tetracyclines can not be avoided, consider separating administration of each agent by several hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: May decrease the excretion of Calcium Salts. Continued concomitant use can also result in metabolic alkalosis.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thyroid Products: Calcium Salts may diminish the therapeutic effect of Thyroid Products.  Management: Separate the doses of the thyroid product and the oral calcium supplement by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trientine: Calcium Salts may decrease the serum concentration of Trientine. Trientine may decrease the serum concentration of Calcium Salts.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin D Analogs: Calcium Salts may enhance the adverse/toxic effect of Vitamin D Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F12780466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ethanol: Ethanol may decrease calcium absorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Food: Caffeine may decrease calcium absorption and increase calcium excretion. Foods that contain maltitol may have an additive laxative effect with the oral solution formulation (contains maltitol).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F144289\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F12769413\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Calcium crosses the placenta. The amount of calcium reaching the fetus is determined by maternal physiological changes. Intestinal absorption of calcium increases during pregnancy. If use is required in pregnant patients with end stage renal disease, fetal harm is not expected if maternal calcium concentrations are monitored and maintained within normal limits as recommended (IOM, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F12769414\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F12769415\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Calcium is excreted in breast milk. The amount of calcium in breast milk is homeostatically regulated and not altered by maternal calcium intake (IOM, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F144303\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral dosage forms must be administered with meals to be effective.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F144302\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Calcium Acetate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     667 mg (200): $157.92",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (PhosLo Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     667 mg (200): $168.43",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Phoslyra Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     667 mg/5 mL (473 mL): $96.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Calcium Acetate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     667 mg (200): $105.18",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     668 (169 Ca) mg (200): $19.85",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Calphron Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     667 mg (200): $25.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Eliphos Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     667 mg (200): $123.74",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F144291\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum calcium (twice weekly during initial dose adjustments), serum phosphorus; serum calcium-phosphorus product; intact parathyroid hormone (iPTH)",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F144294\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corrected total serum calcium (K/DOQI, 2003): CKD stages 3 and 4: 8.4-10.2 mg/dL (2.1-2.6 mmol/L); CKD stage 5: 8.4-9.5 mg/dL (2.1-2.37 mmol/L); KDIGO guidelines recommend maintaining normal ranges for all stages of CKD (3-5D) (KDIGO, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Phosphorus (K/DOQI, 2003):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CKD stages 3 and 4: 2.7-4.6 mg/dL (0.87-1.48mmol/L) (adults); maintain within age-appropriate limits (children)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     CKD stage 5 (including those treated with dialysis): 3.5-5.5 mg/dL (1.13-1.78 mmol/L) (children &gt;12 years and adults); 4-6 mg/dL (1.29-1.94 mmol/L) (children 1-12 years)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     KDIGO guidelines recommend maintaining normal ranges for CKD stages 3-5 and lowering elevated phosphorus levels toward the normal range for CKD stage 5D (KDIGO, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Serum calcium-phosphorus product (K/DOQI, 2003): CKD stage 3-5: &lt;55 mg",
"     <sup>",
"      2",
"     </sup>",
"     /dL",
"     <sup>",
"      2",
"     </sup>",
"     (children &gt;12 years and adults); &lt;65 mg",
"     <sup>",
"      2",
"     </sup>",
"     /dL",
"     <sup>",
"      2",
"     </sup>",
"     (children &le;12 years)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     PTH: Whole molecule, immunochemiluminometric assay (ICMA): 1.0-5.2 pmol/L; whole molecule, radioimmunoassay (RIA): 10.0-65.0 pg/mL; whole molecule, immunoradiometric, double antibody (IRMA): 1.0-6.0 pmol/L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Target ranges by stage of chronic kidney disease (KDIGO, 2009): CKD stage 3-5: Optimal iPTH is unknown; maintain normal range (assay-dependent); CKD stage 5D: Maintain iPTH within 2-9 times the upper limit of normal for the assay used",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5549431\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acid Mantle (MX);",
"     </li>",
"     <li>",
"      Everose (GB);",
"     </li>",
"     <li>",
"      Hypophos (IN);",
"     </li>",
"     <li>",
"      Phos-Ex (DE);",
"     </li>",
"     <li>",
"      Phosbine (KP);",
"     </li>",
"     <li>",
"      PhosEx (GB);",
"     </li>",
"     <li>",
"      PhosLo (GB, KP);",
"     </li>",
"     <li>",
"      Phosphosorb (DE);",
"     </li>",
"     <li>",
"      Phostat (IN);",
"     </li>",
"     <li>",
"      Proca (TW);",
"     </li>",
"     <li>",
"      Procal (TW);",
"     </li>",
"     <li>",
"      Renacet (GB);",
"     </li>",
"     <li>",
"      Royen (CO, UY)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F144281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Combines with dietary phosphate to form insoluble calcium phosphate which is excreted in feces",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F144298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Requires vitamin D; minimal unless chronic, high doses are given; calcium is absorbed in soluble, ionized form; solubility of calcium is increased in an acid environment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Primarily feces (as unabsorbed calcium); urine (20%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of Medicine),",
"      <i>",
"       Dietary Reference Intakes for Calcium and Vitamin D",
"      </i>",
"      , Washington, DC: The National Academies Press, 2011.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kaiser W, Biesenbach G, Kramar R, et al, &ldquo;Calcium Free Hemodialysis: An Effective Therapy in Hypercalcemic Crisis - Report of Four Cases,&rdquo;",
"      <i>",
"       Intensive Care Med",
"      </i>",
"      , 1989, 15(7):471-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/48/39685/abstract-text/2600293/pubmed\" id=\"2600293\" target=\"_blank\">",
"        2600293",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Guideline 1. Evaluation of Calcium and Phosphorus Metabolism.&rdquo; Available at  file://www.kidney.org/professionals/KDOQI/guidelines_pedbone/guide1.htm",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      \"K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease, Guideline 13. Treatment of Bone Disease in Chronic Kidney Disease.\" Available at file://www.kidney.org/professionals/KDOQI/guidelines_bone/index.htm",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      \"K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease,\" 2002. Available at file://www.kidney.org/professionals/KDOQI/guidelines_ckd/toc.htm",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, \"KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD),\"",
"      <i>",
"       Kidney Int Suppl",
"      </i>",
"      , 2009, 76(S113):1-130.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/48/39685/abstract-text/19644521/pubmed\" id=\"19644521\" target=\"_blank\">",
"        19644521",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?38/48/39685/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Texier D, Chevallier P, Perrotin D, et al, &ldquo;Hypercalcemia Associated With Resorbable Haemostatic Compresses,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1982, 1(8273):688-9.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9184 Version 43.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-41.78.124.10-D70169F40B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39685=[""].join("\n");
var outline_f38_48_39685=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144308\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4663225\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144324\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144311\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12769425\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682399\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15682400\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144293\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144278\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144296\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144295\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144331\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144322\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144299\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144282\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298930\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144287\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12780466\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144289\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12769413\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12769414\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12769415\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144303\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144302\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144291\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144294\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5549431\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144281\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144298\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9184\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9184|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?7/38/7780?source=related_link\">",
"      Calcium acetate: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?20/51/21301?source=related_link\">",
"      Calcium acetate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_48_39686="Juvenile cirrhosis - high power";
var content_f38_48_39686=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    A 14-year-old girl with juvenile cirrhosis that was complicated by portal hypertension with esophageal varices and ascites (high power, H&amp;E)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 286px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Eosinophilic inclusion bodies (arrows) are primarily periportal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39686=[""].join("\n");
var outline_f38_48_39686=null;
var title_f38_48_39687="WHO length for age boys 0 to 24 months";
var content_f38_48_39687=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67950%7EPEDS%2F80511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67950%7EPEDS%2F80511&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 587px\">",
"   <div class=\"ttl\">",
"    Length-for-age percentiles, boys birth to 24 months, WHO growth standards",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 567px; height: 459px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     WHO: World Health Organization.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention based on data from the WHO Child Growth Standards.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 587px\">",
"   <div class=\"ttl\">",
"    Length-for-age percentiles, girls 0 to 24 months, WHO growth standards",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 567px; height: 459px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     WHO: World Health Organization.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention based on data from the WHO Child Growth Standards.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39687=[""].join("\n");
var outline_f38_48_39687=null;
var title_f38_48_39688="Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis";
var content_f38_48_39688=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/48/39688/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39688/contributors\">",
"     Peter H Hwang, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39688/contributors\">",
"     Anne Getz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/48/39688/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39688/contributors\">",
"     Daniel G Deschler, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39688/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/48/39688/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39688/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/48/39688/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute rhinosinusitis (ARS) is defined as symptomatic inflammation of the nasal cavity and paranasal sinuses lasting less than four weeks. The term \"rhinosinusitis\" is preferred to \"sinusitis\" since inflammation of the sinuses rarely occurs without concurrent inflammation of the nasal mucosa [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common etiology of ARS is a viral infection associated with the common cold. Viral rhinosinusitis is complicated by acute bacterial infection in only 0.5 to 2.0 percent of episodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/2\">",
"     2",
"    </a>",
"    ]. Uncomplicated acute viral rhinosinusitis (AVRS) typically resolves in 7 to 10 days. Acute bacterial rhinosinusitis (ABRS) also is most commonly a self-limited disease, with 75 percent of cases resolving without treatment in one month. Rarely, patients with untreated bacterial disease may develop serious complications. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/25/11674?source=see_link\">",
"     \"Orbital cellulitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Distinguishing AVRS related to colds and influenza-like illnesses from bacterial infection is a frequent challenge to the primary care clinician. Antibiotics are indicated for ABRS, but are ineffective and not recommended for AVRS. Despite the overwhelming prevalence of a viral etiology, however, in the late 1990s, 92 percent of patients in the United Kingdom [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/3\">",
"     3",
"    </a>",
"    ] and 85 to 98 percent of patients in the United States (US) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/4\">",
"     4",
"    </a>",
"    ] were prescribed an antibiotic when seen for an upper respiratory or sinus infection. Active initiatives to limit the use of antibiotics for upper respiratory infections are ongoing in Europe and the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will address the clinical manifestations and diagnosis of acute rhinosinusitis. The treatment of acute rhinosinusitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/15/2297?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other topics separately discuss the diagnosis or management of related conditions as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic rhinosinusitis (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link\">",
"       \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/4/30794?source=see_link\">",
"       \"Management of chronic rhinosinusitis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The common cold (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/55/24440?source=see_link\">",
"       \"The common cold in adults: Diagnosis and clinical features\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/52/30537?source=see_link\">",
"       \"The common cold in adults: Treatment and prevention\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Fungal sinusitis (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8775?source=see_link&amp;anchor=H5#H5\">",
"       \"Fungal rhinosinusitis\", section on 'Acute fungal sinusitis'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11972301\">",
"    <span class=\"h1\">",
"     CLASSIFICATION OF RHINOSINUSITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classification of rhinosinusitis is based upon symptom duration.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acute rhinosinusitis &mdash; symptoms for less than four weeks",
"     </li>",
"     <li>",
"      Subacute rhinosinusitis &mdash; symptoms for 4 to 12 weeks",
"     </li>",
"     <li>",
"      Chronic rhinosinusitis &mdash; persists greater than 12 weeks (",
"      <a class=\"graphic graphic_figure graphicRef75972 \" href=\"mobipreview.htm?28/15/28926\">",
"       figure 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Recurrent acute rhinosinusitis &mdash; four or more episodes of ARS per year, with interim symptom resolution [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/7\">",
"       7",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acute rhinosinusitis is further specified as acute bacterial rhinosinusitis (ABRS) or acute viral rhinosinusitis (AVRS).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rhinosinusitis affects more than 30 million adults in the United States annually [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/7\">",
"     7",
"    </a>",
"    ]. About one in seven persons in the United States and in other western countries will have an episode of sinusitis in a year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/8\">",
"     8",
"    </a>",
"    ]. Incidence is higher in women than men, and among adults, highest in those aged 45 to 74 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/9\">",
"     9",
"    </a>",
"    ]. &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    Direct costs of sinusitis in the US, resulting from medications, outpatient and emergency room visits, and ancillary tests and procedures, are estimated at $3 billion per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/7,10\">",
"     7,10",
"    </a>",
"    ]. The socioeconomic impact is further magnified by indirect costs from decreased productivity, days lost from work, and impaired quality of life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast majority of cases of acute rhinosinusitis (ARS) are due to viral infection. Acute bacterial infection occurs in only 0.5 to 2.0 percent of episodes. The most common viruses, determined by maxillary sinus puncture and aspiration, are rhinovirus, influenza virus, and parainfluenza virus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acute viral rhinosinusitis (AVRS) begins with viral inoculation via direct contact with conjunctiva or nasal mucosa. Viral replication in a nonimmune individual leads to detectable viral levels in nasal secretions within 8 to 10 hours. Symptoms, if they develop, usually present in the first day after inoculation.",
"   </p>",
"   <p>",
"    Viral rhinitis spreads to the paranasal sinuses by systemic or direct routes. Nose blowing may be an important mechanism; positive intranasal pressures generated during nose blowing may propel contaminated fluid from the nasal cavity into the paranasal sinuses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/12\">",
"     12",
"    </a>",
"    ]. Inflammation follows, resulting in sinonasal hypersecretion and increased vascular permeability followed by transudation of fluid into the nasal cavity and sinuses. Viruses also can exert a direct toxic effect on nasal cilia, impairing mucociliary clearance. A combination of mucosal edema, copious thickened secretions, and ciliary dyskinesia results in sinus obstruction and perpetuates the disease process [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Community-acquired acute bacterial rhinosinusitis (ABRS) occurs when bacteria secondarily infect an inflamed sinus cavity. This most commonly occurs as a complication of viral infection. Other predisposing conditions associated with ABRS include allergy, mechanical obstruction of the nose, swimming, odontogenic infection, intranasal cocaine use, impaired mucociliary clearance (eg, cystic fibrosis, cilial dysfunction), immunodeficiency, and other factors that impair sinus drainage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H98446099\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11975880\">",
"    <span class=\"h2\">",
"     Community-acquired acute bacterial rhinosinusitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal respiratory flora in adults typically include coagulase-negative Staphylococci, Corynebacterium, and Staphylococcus aureus. The most common bacteria associated with acute bacterial rhinosinusitis (ABRS) are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, with the first two comprising approximately 75 percent of cases of ABRS (",
"    <a class=\"graphic graphic_table graphicRef81702 \" href=\"mobipreview.htm?4/49/4891\">",
"     table 1",
"    </a>",
"    ). When ABRS is due to extension of dental root infection into the sinus cavity, microaerophilic and anaerobic bacteria may be identified.",
"   </p>",
"   <p>",
"    Community-acquired ABRS is typically caused by a single pathogen in high concentration (&gt;100 colony-forming units",
"    <span class=\"nowrap\">",
"     [CFU]/mL),",
"    </span>",
"    although two distinct pathogens in high concentrations are isolated in approximately 25 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11975718\">",
"    <span class=\"h2\">",
"     Nosocomial bacterial rhinosinusitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with extended stays in the intensive care unit (ICU), burn victims, and those with prolonged intubation, particularly nasotracheal, are at increased risk of developing ABRS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/16\">",
"     16",
"    </a>",
"    ]. Acute sinusitis affects 1 to 8 percent of patients in the ICU and usually presents as fever of unknown origin.",
"   </p>",
"   <p>",
"    Gram-negative organisms including Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter species, Proteus mirabilis, Serratia marcescens, and some Gram-positive cocci, in particular S. aureus, predominate in nosocomial infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/1,17\">",
"     1,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11975803\">",
"    <span class=\"h2\">",
"     Acute invasive fungal rhinosinusitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute fulminant invasive fungal rhinosinusitis (IFRS) is a disease of immunosuppressed patients or patients with poorly-controlled diabetes. The most common species are Mucor, Rhizopus, Aspergillus, Absidia, and Basidiobolus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8775?source=see_link\">",
"     \"Fungal rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of acute rhinosinusitis include nasal congestion and obstruction, purulent nasal discharge, maxillary tooth discomfort, and facial pain or pressure that is worse when bending forward [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. Other signs and symptoms include fever, fatigue, cough, hyposmia or anosmia, ear pressure or fullness, headache, and halitosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Indications for urgent referral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with high fevers (&gt;39&deg;C or 102&deg;F) and severe headache warrant immediate evaluation and probable imaging.",
"   </p>",
"   <p>",
"    The finding of any of the following should lead to urgent referral to a specialist or emergency department for the possibility of complications of sinusitis, including intracranial and orbital extension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/22\">",
"     22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abnormal vision (diplopia, blindness)",
"     </li>",
"     <li>",
"      Change in mental status",
"     </li>",
"     <li>",
"      Periorbital edema",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of acute rhinosinusitis (ARS) is based upon clinical signs and symptoms. Diagnostic testing is not indicated in the initial evaluation in the absence of signs suggesting complicated disease. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Diagnostic tests'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H5\">",
"     'Indications for urgent referral'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    One set of criteria for the diagnosis of ARS identifies a group of major and minor symptoms (",
"    <a class=\"graphic graphic_table graphicRef83163 \" href=\"mobipreview.htm?19/58/20395\">",
"     table 2",
"    </a>",
"    ) and has been used in several randomized trials to establish the diagnosis.",
"   </p>",
"   <p>",
"    Analysis of the predictive value of multiple signs and symptoms has identified the following two criteria as most highly predictive of acute sinusitis, whether viral or bacterial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Purulent rhinorrhea",
"     </li>",
"     <li>",
"      Nasal congestion and facial",
"      <span class=\"nowrap\">",
"       pain/pressure",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis is further supported by the presence of secondary symptoms, including anosmia, ear fullness, cough, and headache.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H98446144\">",
"    <span class=\"h2\">",
"     Distinguishing bacterial from viral infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical presentation is unfortunately of limited accuracy in distinguishing pure viral rhinosinusitis from secondary bacterial infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/23\">",
"     23",
"    </a>",
"    ]. A systematic review found no studies of the predictive value of clinical criteria for the diagnosis of acute bacterial rhinosinusitis that were validated on the basis of bacterial cultures of sinus aspirates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several clinical criteria have been suggested to distinguish bacterial and viral infection, based upon studies with methodological flaws, including the lack of a gold standard for establishing the diagnosis, differing criteria for determining response, and heterogeneous patient selection criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/4,19,25,26\">",
"     4,19,25,26",
"    </a>",
"    ]. Criteria suggested by Berg and Carenfelt for bacterial sinus infection have been used in some studies, but are based upon symptom correlation with the presence of purulence (not culture results) in specimens obtained by antral puncture and thus may not distinguish bacterial from viral infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Symptom duration and progression",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of viral rhinosinusitis is based primarily upon history of the quality, duration, and progression of symptoms. Partial or complete resolution of symptoms within 7 to 10 days following the onset of an upper respiratory tract infection is indicative of acute viral rhinosinusitis (AVRS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/7,27-31\">",
"     7,27-31",
"    </a>",
"    ]. The classic triad for ABRS in adults (headache, facial pain, fever) occurs infrequently [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/24\">",
"     24",
"    </a>",
"    ]. Criteria to distinguish ABRS and AVRS have been developed by several expert panels.",
"   </p>",
"   <p>",
"    A 2001 panel organized by the Centers for Disease Control, including representatives of the American Academy of Family Physicians, American College of Physicians, American Society of Internal Medicine, and the Infectious Diseases Society of America, identified the following criteria as suggestive of acute bacterial rhinosinusitis (ABRS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/4,32,33\">",
"     4,32,33",
"    </a>",
"    ]:",
"    <br/>",
"    <br/>",
"    Rhinosinusitis symptoms lasting",
"    <strong>",
"     seven or more days",
"    </strong>",
"    and",
"    <strong>",
"     any",
"    </strong>",
"    of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Purulent nasal discharge, or",
"     </li>",
"     <li>",
"      Maxillary tooth or facial pain, especially unilateral, or",
"     </li>",
"     <li>",
"      Unilateral maxillary sinus tenderness, or",
"     </li>",
"     <li>",
"      Worsening symptoms after initial improvement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Worsening of rhinosinusitis symptoms after an initial improvement (double worsening) is particularly suggestive of ABRS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/7,31\">",
"     7,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Guidelines published in 2012 from the Infectious Diseases Society of America suggest the following three criteria, with recognition that only 60 percent of adults with symptoms persisting 7 to 10 days have a bacterial etiology identified when sinus aspirate is performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <em>",
"       Persistent",
"      </em>",
"      symptoms or signs of ARS lasting 10 or more days without evidence of clinical improvement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Persistent symptoms commonly involve nasal discharge, whereas the presence of fever, headache, or facial pain is more variable. Although symptoms often persistent for more than 10 days with a viral infection, typically there is some improvement in the clinical course by day 10 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Onset of",
"      <em>",
"       severe",
"      </em>",
"      symptoms or signs of high fever (&gt;39&deg;C or 102&deg;F) and purulent nasal discharge or facial pain for at least three to four consecutive days at the beginning of illness.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Fever associated with an acute viral upper respiratory infection generally subsides in 24 to 48 hours, and purulent nasal discharge usually occurs after four or five days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Onset with",
"      <em>",
"       worsening",
"      </em>",
"      symptoms or signs (new onset fever, headache, nasal discharge) following a typical viral upper respiratory infection that lasted five to six days and were initially improving.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11972383\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute rhinosinusitis (ARS) is to be distinguished from chronic rhinosinusitis on the basis of the duration of symptoms. Patients with acute rhinosinusitis have symptoms for four weeks or less (",
"    <a class=\"graphic graphic_figure graphicRef75972 \" href=\"mobipreview.htm?28/15/28926\">",
"     figure 1",
"    </a>",
"    ). Chronic rhinosinusitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis of ARS involves other conditions that can cause symptoms of rhinitis, facial pain, headache, or dental pain. The following are to be considered:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The common cold &mdash; Patients with a cold typically primarily have symptoms of rhinitis (sneezing and anterior or posterior rhinorrhea), often with a sore throat or cough. Symptoms of acute viral sinusitis are also commonly present, but rhinitis is generally predominant. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/55/24440?source=see_link\">",
"       \"The common cold in adults: Diagnosis and clinical features\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Noninfectious rhinitis &mdash; Allergic rhinitis and nonallergic vasomotor rhinitis are common causes of rhinorrhea and nasal congestion. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/17/30999?source=see_link\">",
"       \"An overview of rhinitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Facial pain &mdash; Multiple conditions may cause facial pain, including neuralgias, temporomandibular joint disorder, cancer pain, or carotodynia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/10/11431?source=see_link\">",
"       \"Overview of craniofacial pain\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Headache &mdash; Frontal sinus pain may represent a variety of headache etiologies, including migraine headaches, tension headaches, and cluster headaches. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34615?source=see_link\">",
"       \"Evaluation of headache in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Dental pain &mdash; While dental infection may be a direct source of bacterial involvement of the maxillary sinuses, patients with dental pain may have referred pain to the sinuses without actual infection. Patients should be asked about prior dental procedures or heat or cold sensitivity in the teeth.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical examination should encompass the usual evaluation for respiratory infection, including assessment of vital signs, eyes, ears, pharynx, teeth, sinus tenderness, lymph nodes, and chest. Pain localized to the sinuses when the patient is asked to bend forward may be more reliable than pain provoked by direct percussion in the diagnosis of rhinosinusitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While direct visualization of the sinuses is not possible, a handheld otoscope or nasal speculum can be used to perform anterior rhinoscopy. Notable exam findings may include diffuse mucosal edema, narrowing of the middle meatus, inferior turbinate hypertrophy, and copious rhinorrhea or purulent discharge. Polyps or septal deviation may be noted incidentally and may indicate preexisting anatomic risk factors for the development of ABRS. Transillumination of the sinuses has limited value as a diagnostic technique [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/38\">",
"     38",
"    </a>",
"    ]. It is of potential use only for examining the maxillary and frontal sinuses and does not distinguish viral from bacterial acute rhinosinusitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TESTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11975385\">",
"    <span class=\"h2\">",
"     Microbiologic culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral culture of nasal secretions is impractical and unnecessary, given the self-limited nature of AVRS.",
"   </p>",
"   <p>",
"    Bacterial culture of material from blind swabs of the nasal cavity or from purulent nasal secretions is not recommended, as results are not reliable. Therefore, patients who require antibiotic therapy will generally be treated empirically in the primary care setting, with antibiotic choice based upon likely pathogen and susceptibility. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/15/2297?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cultures (obtained by endoscopy) are indicated in patients with documented sinusitis who are not responding to empiric antibiotic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11976004\">",
"    <span class=\"h3\">",
"     Endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic cultures can be performed with minimal morbidity in the otolaryngologist's office (",
"    <a class=\"graphic graphic_picture graphicRef54181 \" href=\"mobipreview.htm?41/50/42799\">",
"     picture 1",
"    </a>",
"    ) and are better tolerated than classic antral puncture with a large bore trocar or needle passed through the canine fossa or inferior meatus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. Endoscopically-guided middle meatal cultures correlated with cultures performed during maxillary antrostomy in 86 percent of patients in one study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/42\">",
"     42",
"    </a>",
"    ] and with maxillary punctures in 90 percent in a small prospective series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endoscopic or sinus aspirate culture, while not indicated in routine medical practice, should be considered if there is a suspicion of intracranial extension of the infection or other serious complications. Culture may also be helpful in patients where atypical pathogens are suspected, including patients with nosocomial sinusitis, immunocompromise, cystic fibrosis, or recent hospitalization.",
"   </p>",
"   <p>",
"    Acute fulminant invasive fungal rhinosinusitis (IFRS), occurring in patients who are immunosuppressed or who have poorly controlled diabetes, is often rapidly progressive and life-threatening. Early diagnosis is of paramount importance. If a diagnosis of IFRS is entertained, immediate consultation of an otolaryngologist is mandated. Diagnosis is made by endoscopic examination and biopsy. Rhinoscopy may show either pale, ischemic mucosa or dusky, purplish mucosa with crusting. Histopathology demonstrates intravascular tissue invasion by fungal organisms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8775?source=see_link&amp;anchor=H5#H5\">",
"     \"Fungal rhinosinusitis\", section on 'Acute fungal sinusitis'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Radiologic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although frequently ordered, radiography of any modality is not indicated in the initial evaluation of uncomplicated acute rhinosinusitis (ARS). However, imaging studies are indicated in patients with clinical signs or symptoms of complicated ABRS, including diminished visual acuity, diplopia, periorbital edema, severe headache, or altered mental status. Imaging may also be helpful in recurrent or treatment-resistant sinusitis to help delineate anatomic blockage of the ostio-meatal complex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/44\">",
"     44",
"    </a>",
"    ]. CT scan is generally acknowledged to be the imaging procedure of choice for the sinus when imaging is indicated. A CT scan with contrast is indicated when there is concern for a suppurative complication such as orbital cellulitis or intracranial infection; a noncontrast CT scan is appropriate in the evaluation of recurrent or treatment-resistant sinusitis. Noncontrast CT is preferable to plain films for its ability to discern bony and soft tissue detail.",
"   </p>",
"   <p>",
"    Common findings of sinusitis on CT include air-fluid levels, mucosal edema, and air bubbles within the sinuses (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68163 \" href=\"mobipreview.htm?31/9/31888\">",
"     image 1",
"    </a>",
"    ). Some form of mucosal abnormality on CT scan may be observed in as many as 42 percent of asymptomatic healthy individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. In one study of 31 patients with self-diagnosed \"colds\" confirmed by viral culture, mucosal thickening, or air-fluid levels of the maxillary sinuses were found on CT scan within two to three days of symptom onset in 87 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/47\">",
"     47",
"    </a>",
"    ]. CT abnormalities were also documented in ethmoid, frontal, and sphenoid sinuses (65, 32, and 39 percent, respectively). Resolution of radiographic abnormalities occurred by two weeks, and no subject received antibiotic therapy.",
"   </p>",
"   <p>",
"    While not helpful in differentiating between viral and bacterial etiology, CT imaging is useful in refuting sinusitis as a diagnosis. Diagnoses such as allergy or nonallergic rhinitis, or atypical facial pain, might be considered in the absence of radiologic evidence of sinonasal mucosal edema or an air-fluid level. It is reasonable to consider CT imaging in patients with persistent symptoms in whom rhinosinusitis is not clearly suspected and one hopes to avoid a trial of empiric antibiotics.",
"   </p>",
"   <p>",
"    Plain sinus films and sinus CT may show sinus fluid levels in patients with both AVRS and ABRS and cannot distinguish between viral and bacterial etiologies. Additionally, the sensitivity and specificity of plain sinus radiography is poor for detecting mucosal thickening of the paranasal sinuses (76 and 79 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. The high false-negative rate is attributable to poor visualization of the ethmoid sinuses in plain films and the high false-positive rate to artifact and the inability to distinguish polyps and nasal masses from fluid or mucosal edema.",
"   </p>",
"   <p>",
"    MRI is not indicated for routine evaluation of ABRS. It provides complementary soft tissue detail and is used in conjunction with CT for the evaluation of complications of acute rhinosinusitis, when extra sinus involvement is suspected. MRI and CT are considered complementary studies for the evaluation of possible orbital or intracranial complications of ABRS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrasonography is of limited use in the diagnosis of ABRS, due to its high operator variability and inferior accuracy relative to other modalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11972580\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of acute viral rhinosinusitis (AVRS), aside from acute bacterial rhinosinusitis (ABRS), are uncommon. While transient hyposmia is frequent, permanent anosmia occurs rarely. Viral-induced anosmia is more common in women and may be associated with a more severe antecedent viral infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39688/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Complications of ABRS, which now rarely occur, are related to local extension into the central nervous system (meningitis), orbit of the eye (orbital cellulitis), orbital tissues (orbital cellulitis or osteitis of the sinus bones). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/25/11674?source=see_link\">",
"     \"Orbital cellulitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute sinus infection may also be a precursor of chronic sinus disease, although this relationship is not well studied. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/53/17234?source=see_link\">",
"       \"Patient information: Sinusitis in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/12/12483?source=see_link\">",
"       \"Patient information: What you should know about antibiotics (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/13/37073?source=see_link\">",
"       \"Patient information: Acute sinusitis (sinus infection) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute rhinosinusitis (ARS), inflammation of the nasal cavity and paranasal sinuses lasts less than four weeks, in contrast to subacute rhinosinusitis (4 to 12 weeks) and chronic rhinosinusitis (&gt;12 weeks). ARS is further subdivided into acute viral rhinosinusitis (AVRS) and acute bacterial rhinosinusitis (ABRS). ABRS occurs in 0.5 to 2.0 percent of episodes. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11972301\">",
"       'Classification of rhinosinusitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      About one in seven adults in Western countries will have an episode of sinusitis annually. Incidence in adults is higher in women than men and among those 45 to 74 years of age. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute bacterial rhinosinusitis (ABRS) accounts for only about 0.5 to 2.0 percent of episodes of ARS. ABRS most commonly occurs as a complication of viral infection, but can be associated with allergic rhinitis or conditions that obstruct the nose or impair local or systemic immune function. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common bacteria associated with ABRS are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, with the first two comprising approximately 75 percent of cases of ABRS. Gram-negative organisms should be considered in nosocomial bacterial rhinosinusitis and fungal etiologies in immunosuppressed patients. (See",
"      <a class=\"local\" href=\"#H98446099\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of ARS is based on the presence of (1) purulent rhinorrhea and (2) nasal congestion and facial pain. Other signs and symptoms include maxillary tooth discomfort, fever, fatigue, cough, hyposmia or anosmia, ear pressure or fullness, headache, and halitosis. Urgent evaluation is indicated for patients with high fever and severe headache; urgent referral for evaluation of intracranial or orbital extension of infection is indicated for patients with abnormal vision, change in mental status, or periorbital edema. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Indications for urgent referral'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms do not accurately distinguish viral from bacterial infection. ABRS is suggested by persistent symptoms or signs of ARS lasting &ge;10 days without clinical improvement, onset of severe symptoms or signs (high fever, purulent nasal discharge, or facial pain) for at least three to four consecutive days at the beginning of illness, or initially symptom improvement followed by worsening symptoms or signs. (See",
"      <a class=\"local\" href=\"#H98446144\">",
"       'Distinguishing bacterial from viral infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cultures from nasal swabs or secretions are inaccurate. Cultures (obtained by endoscopy) are indicated in patients with documented sinusitis who are not responding to empiric antibiotic therapy or in patients in whom atypical pathogens are suspected because of nosocomial infection or immunocompromise. Radiography is not indicated in the initial evaluation of uncomplicated ARS. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnostic tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of ABRS occur rarely and include orbital cellulitis, orbital cellulitis, osteitis, and meningitis. (See",
"      <a class=\"local\" href=\"#H11972580\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/1\">",
"      Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004; 131:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/2\">",
"      Fokkens W, Lund V, Mullol J, European Position Paper on Rhinosinusitis and Nasal Polyps Group. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 2007; 45:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/3\">",
"      Ashworth M, Charlton J, Ballard K, et al. Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995-2000. Br J Gen Pract 2005; 55:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/4\">",
"      Hickner JM, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 134:498.",
"     </a>",
"    </li>",
"    <li>",
"     Get Smart: Know when antibioitcs work. Centers for Disease Control and Prevention. file://www.cdc.gov/getsmart/resources/related-programs.html (Accessed on March 27, 2012).",
"    </li>",
"    <li>",
"     The antibiotic awareness campaign. file://www.nhs.uk/NHSEngland/ARC/Pages/AboutARC.aspx (Accessed on May 04, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/7\">",
"      Rosenfeld RM, Andes D, Bhattacharyya N, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007; 137:S1.",
"     </a>",
"    </li>",
"    <li>",
"     Statistics by country for sinusitis. file://www.rightdiagnosis.com/s/sinusitis/stats-country.htm (Accessed on March 27, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/9\">",
"      Pleis JR, Lucas JW, Ward BW. Summary health statistics for U.S. adults: National Health Interview Survey, 2008. Vital Health Stat 10 2009; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/10\">",
"      Anon JB, Jacobs MR, Poole MD, et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004; 130:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/11\">",
"      Gwaltney JM Jr. Acute community-acquired sinusitis. Clin Infect Dis 1996; 23:1209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/12\">",
"      Gwaltney JM Jr, Hendley JO, Phillips CD, et al. Nose blowing propels nasal fluid into the paranasal sinuses. Clin Infect Dis 2000; 30:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/13\">",
"      Mogensen C, Tos M. Quantitative histology of the maxillary sinus. Rhinology 1977; 15:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/14\">",
"      Scheid DC, Hamm RM. Acute bacterial rhinosinusitis in adults: part I. Evaluation. Am Fam Physician 2004; 70:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/15\">",
"      Evans FO Jr, Sydnor JB, Moore WE, et al. Sinusitis of the maxillary antrum. N Engl J Med 1975; 293:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/16\">",
"      Bach A, Boehrer H, Schmidt H, Geiss HK. Nosocomial sinusitis in ventilated patients. Nasotracheal versus orotracheal intubation. Anaesthesia 1992; 47:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/17\">",
"      Casiano RR, Cohn S, Villasuso E 3rd, et al. Comparison of antral tap with endoscopically directed nasal culture. Laryngoscope 2001; 111:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/18\">",
"      Schell WA. Unusual fungal pathogens in fungal rhinosinusitis. Otolaryngol Clin North Am 2000; 33:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/19\">",
"      Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997; 117:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/20\">",
"      Piccirillo JF. Clinical practice. Acute bacterial sinusitis. N Engl J Med 2004; 351:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/21\">",
"      Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc 2011; 86:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/22\">",
"      Ah-See KW, Evans AS. Sinusitis and its management. BMJ 2007; 334:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/23\">",
"      Young J, De Sutter A, Merenstein D, et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet 2008; 371:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/24\">",
"      Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 2012; 54:e72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/25\">",
"      Williams JW Jr, Simel DL. Does this patient have sinusitis? Diagnosing acute sinusitis by history and physical examination. JAMA 1993; 270:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/26\">",
"      Hansen JG, Schmidt H, Rosborg J, Lund E. Predicting acute maxillary sinusitis in a general practice population. BMJ 1995; 311:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/27\">",
"      Berg O, Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol 1988; 105:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/28\">",
"      Axelsson A, Runze U. Symptoms and signs of acute maxillary sinusitis. ORL J Otorhinolaryngol Relat Spec 1976; 38:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/29\">",
"      Axelsson A, Runze U. Comparison of subjective and radiological findings during the course of acute maxillary sinusitis. Ann Otol Rhinol Laryngol 1983; 92:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/30\">",
"      Williams JW Jr, Simel DL, Roberts L, Samsa GP. Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination. Ann Intern Med 1992; 117:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/31\">",
"      Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005; 60:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/32\">",
"      Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001; 134:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/33\">",
"      Snow V, Mottur-Pilson C, Hickner JM, et al. Principles of appropriate antibiotic use for acute sinusitis in adults. Ann Intern Med 2001; 134:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/34\">",
"      Gwaltney JM Jr, Scheld WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992; 90:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/35\">",
"      Hadley JA, M&ouml;sges R, Desrosiers M, et al. Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis. Laryngoscope 2010; 120:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/36\">",
"      Gwaltney JM Jr, Hendley JO, Simon G, Jordan WS Jr. Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA 1967; 202:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/37\">",
"      Wilson JF. In the clinic. Acute sinusitis. Ann Intern Med 2010; 153:ITC31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/38\">",
"      Low DE, Desrosiers M, McSherry J, et al. A practical guide for the diagnosis and treatment of acute sinusitis. CMAJ 1997; 156 Suppl 6:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/39\">",
"      Benninger MS, Appelbaum PC, Denneny JC, et al. Maxillary sinus puncture and culture in the diagnosis of acute rhinosinusitis: the case for pursuing alternative culture methods. Otolaryngol Head Neck Surg 2002; 127:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/40\">",
"      Benninger MS, Payne SC, Ferguson BJ, et al. Endoscopically directed middle meatal cultures versus maxillary sinus taps in acute bacterial maxillary rhinosinusitis: a meta-analysis. Otolaryngol Head Neck Surg 2006; 134:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/41\">",
"      Talbot GH, Kennedy DW, Scheld WM, et al. Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis. Clin Infect Dis 2001; 33:1668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/42\">",
"      Gold SM, Tami TA. Role of middle meatus aspiration culture in the diagnosis of chronic sinusitis. Laryngoscope 1997; 107:1586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/43\">",
"      Vogan JC, Bolger WE, Keyes AS. Endoscopically guided sinonasal cultures: a direct comparison with maxillary sinus aspirate cultures. Otolaryngol Head Neck Surg 2000; 122:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/44\">",
"      Osguthorpe JD, Hadley JA. Rhinosinusitis. Current concepts in evaluation and management. Med Clin North Am 1999; 83:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/45\">",
"      Havas TE, Motbey JA, Gullane PJ. Prevalence of incidental abnormalities on computed tomographic scans of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 1988; 114:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/46\">",
"      Bolger WE, Butzin CA, Parsons DS. Paranasal sinus bony anatomic variations and mucosal abnormalities: CT analysis for endoscopic sinus surgery. Laryngoscope 1991; 101:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/47\">",
"      Gwaltney JM Jr, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med 1994; 330:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/48\">",
"      Berger G, Steinberg DM, Popovtzer A, Ophir D. Endoscopy versus radiography for the diagnosis of acute bacterial rhinosinusitis. Eur Arch Otorhinolaryngol 2005; 262:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/49\">",
"      Lau J, Zucker D, Engels EA, et al. Diagnosis and treatment of acute bacterial rhinosinusitis. Evid Rep Technol Assess (Summ) 1999; :1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/50\">",
"      Engels EA, Terrin N, Barza M, Lau J. Meta-analysis of diagnostic tests for acute sinusitis. J Clin Epidemiol 2000; 53:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/51\">",
"      Varonen H, M&auml;kel&auml; M, Savolainen S, et al. Comparison of ultrasound, radiography, and clinical examination in the diagnosis of acute maxillary sinusitis: a systematic review. J Clin Epidemiol 2000; 53:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/52\">",
"      Sugiura M, Aiba T, Mori J, Nakai Y. An epidemiological study of postviral olfactory disorder. Acta Otolaryngol Suppl 1998; 538:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39688/abstract/53\">",
"      Harris R, Davidson TM, Murphy C, et al. Clinical evaluation and symptoms of chemosensory impairment: one thousand consecutive cases from the Nasal Dysfunction Clinic in San Diego. Am J Rhinol 2006; 20:101.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6871 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-41.78.124.10-D70169F40B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39688=[""].join("\n");
var outline_f38_48_39688=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11972301\">",
"      CLASSIFICATION OF RHINOSINUSITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H98446099\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11975880\">",
"      Community-acquired acute bacterial rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11975718\">",
"      Nosocomial bacterial rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11975803\">",
"      Acute invasive fungal rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Indications for urgent referral",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H98446144\">",
"      Distinguishing bacterial from viral infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Symptom duration and progression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11972383\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSTIC TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11975385\">",
"      Microbiologic culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11976004\">",
"      - Endoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Radiologic studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11972580\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6871\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6871|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?31/9/31888\" title=\"diagnostic image 1\">",
"      Coronal CT in pt with ABRS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6871|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/15/28926\" title=\"figure 1\">",
"      Classify rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6871|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/50/42799\" title=\"picture 1\">",
"      Purulent drainage ABRS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6871|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?4/49/4891\" title=\"table 1\">",
"      Pathogen distribution ABRS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/58/20395\" title=\"table 2\">",
"      Symptom criteria dx sinusitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/15/2297?source=related_link\">",
"      Acute sinusitis and rhinosinusitis in adults: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/17/30999?source=related_link\">",
"      An overview of rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=related_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34615?source=related_link\">",
"      Evaluation of headache in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8775?source=related_link\">",
"      Fungal rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/4/30794?source=related_link\">",
"      Management of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/25/11674?source=related_link\">",
"      Orbital cellulitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/10/11431?source=related_link\">",
"      Overview of craniofacial pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/13/37073?source=related_link\">",
"      Patient information: Acute sinusitis (sinus infection) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/53/17234?source=related_link\">",
"      Patient information: Sinusitis in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/12/12483?source=related_link\">",
"      Patient information: What you should know about antibiotics (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/55/24440?source=related_link\">",
"      The common cold in adults: Diagnosis and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/52/30537?source=related_link\">",
"      The common cold in adults: Treatment and prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_48_39689="Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults";
var content_f38_48_39689=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/48/39689/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39689/contributors\">",
"     Steven R Mess&eacute;, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39689/contributors\">",
"     Robert S Schwartz, MD, FACC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39689/contributors\">",
"     Joseph K Perloff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/48/39689/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39689/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39689/contributors\">",
"     Thomas P Graham, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/48/39689/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39689/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/48/39689/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/48/39689/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stroke can be associated with abnormalities of the atrial septum, specifically patent foramen ovale (PFO), atrial septal defect (ASD), and atrial septal aneurysm (ASA).",
"   </p>",
"   <p>",
"    The relationship between PFO, ASD, or ASA and ischemic neurologic complications will be reviewed here. Treatment is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/63/14328?source=see_link\">",
"     \"Treatment of atrial septal abnormalities (PFO, ASD, and ASA) for prevention of stroke in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SOURCES OF EMBOLI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emboli leading to stroke or to transient ischemic attack can originate in either the systemic venous circulation (paradoxical emboli) or in the systemic arterial circulation. Some patients with cryptogenic stroke have a patent foramen ovale (PFO), an atrial septal defect, or an atrial septal aneurysm that can be identified by echocardiography. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/4/12361?source=see_link\">",
"     \"Echocardiography in detection of intracardiac sources of embolism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/10/40105?source=see_link\">",
"     \"Cryptogenic stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These structures have been implicated in the pathogenesis of embolic events. However, identification of one or more of these atrial septal abnormalities in a patient with an ischemic event does not prove a causal relationship since other sources or conduits of embolism may also be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Paradoxical emboli",
"    </span>",
"    &nbsp;&mdash;&nbsp;A paradoxical embolus originates in the systemic venous circulation and enters the systemic arterial circulation through a PFO, atrial septal defect, ventricular septal defect, or extracardiac communication such as a pulmonary arteriovenous malformation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. The embolus can originate in veins of the lower extremities, in pelvic veins, in an atrial septal aneurysm, or from a clot around the edges of a PFO. Case reports have described patients with an \"impending\" paradoxical embolus due to a trapped embolus in a PFO [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Source of the embolus'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients with paradoxical emboli can present with cryptogenic stroke. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/10/40105?source=see_link\">",
"     \"Cryptogenic stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     PFO and atrial septal defect",
"    </span>",
"    &nbsp;&mdash;&nbsp;The foramen ovale and its flap-like valve between the right and left atrium are important components of the fetal circulation. In the developing fetus, oxygenated blood from the umbilical vein enters the right atrium via the inferior vena cava and is shunted into the left atrium, circumventing the non-inflated lungs. After birth, a relative increase in left atrial pressure closes the flap, and adhesions frequently result in a structurally intact atrial septum. However, in approximately 25 percent of adults, the foramen ovale remains patent and acts as a potential right-to-left shunt (",
"    <a class=\"graphic graphic_movie graphicRef78654 \" href=\"mobipreview.htm?12/48/13057\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef56656 \" href=\"mobipreview.htm?32/20/33094\">",
"     movie 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/32/3593?source=see_link\">",
"     \"Patent foramen ovale\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Less commonly, an open communication (a tissue defect) called an atrial septal defect persists between the atria after septation. This may be visualized on transthoracic (",
"    <a class=\"graphic graphic_movie graphicRef80448 \" href=\"mobipreview.htm?6/56/7040\">",
"     movie 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef54350 \" href=\"mobipreview.htm?40/32/41487\">",
"     movie 4",
"    </a>",
"    ) or transesophageal echocardiography (",
"    <a class=\"graphic graphic_movie graphicRef79348 \" href=\"mobipreview.htm?22/39/23167\">",
"     movie 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The pathophysiology and clinical features of PFOs and atrial septal defects are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/27/16825?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathophysiology and clinical features of atrial septal defects in adults\", section on 'Embryology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/27/16825?source=see_link&amp;anchor=H4#H4\">",
"     \"Pathophysiology and clinical features of atrial septal defects in adults\", section on 'Classification'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Right-to-left shunting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Right-to-left shunting through a PFO or an atrial septal defect can result in a paradoxical embolus (see",
"    <a class=\"local\" href=\"#H3\">",
"     'Paradoxical emboli'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Since a transient right-to-left gradient is sufficient to induce shunting, such shunts commonly occur in individuals with no net right-to-left shunt (ie, those with no net intracardiac shunt or a net left to right shunt). Chronic elevation in right heart pressures (eg, Eisenmenger syndrome) is not required or generally present.",
"   </p>",
"   <p>",
"    Transient increases in right atrial pressure occur in normal individuals during early ventricular systole (",
"    <a class=\"graphic graphic_movie graphicRef78654 \" href=\"mobipreview.htm?12/48/13057\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef56656 \" href=\"mobipreview.htm?32/20/33094\">",
"     movie 2",
"    </a>",
"    ), during the Valsalva maneuver, and with repetitive cough [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, a persistent, large Eustachian valve or a Chiari network may direct inferior vena caval blood toward the midportion of the atrial septum and potentially into the left atrium and systemic circulation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/32/3593?source=see_link&amp;anchor=H6#H6\">",
"     \"Patent foramen ovale\", section on 'Eustachian valve and Chiari network'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    During the Valsalva maneuver, transient right-to-left shunting in patients with a PFO or an atrial septal defect can be induced during the straining and release phases. During the straining phase, the right atrial pressure rises disproportionately, and during release there is a sudden increase in systemic venous return into the right atrium. Physiologic conditions associated with a Valsalva maneuver include straining to defecate, lifting or pushing heavy objects, and vigorous repetitive cough. In one series of 148 patients with a PFO, 84 (57 percent) had right-to-left shunting at rest, and 136 (92 percent) had right-to-left shunting with straining or coughing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An uncommon consequence of intermittent right-to-left shunting is the platypnea-orthodeoxia syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/5\">",
"     5",
"    </a>",
"    ]. This disorder is defined as an orthostatic right-to-left shunt across an atrial septal defect or PFO resulting in decreases in oxygen saturation when changing position from prone to upright. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/32/3593?source=see_link&amp;anchor=H13#H13\">",
"     \"Patent foramen ovale\", section on 'Platypnea-orthodeoxia syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Atrial septal aneurysm",
"    </span>",
"    &nbsp;&mdash;&nbsp;An atrial septal aneurysm is defined as redundant and mobile interatrial septal tissue in the region of the fossa ovalis with phasic excursion of at least 10 to 15 mm during the cardiorespiratory cycle. Atrial septal aneurysms have been classified according to their oscillation (intrusion) into the left or right atrium and according to their motion during the respiratory cycle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/12\">",
"     12",
"    </a>",
"    ]. Most investigators have defined an atrial septal aneurysm as an excursion of at least 10 or 15 mm. The aneurysm may either bulge persistently into the right or left atrium or exhibit striking oscillations from right atrium to left atrium during respiration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/12-14\">",
"     12-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Atrial septal aneurysm is most commonly an incidental finding. However, some patients with atrial septal aneurysm present with systemic thromboembolism and some present with symptoms and signs of significant intracardiac shunting via one or more associated atrial septal defects. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/48/5896?source=see_link\">",
"     \"Identification and assessment of atrial septal defects in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of atrial septal aneurysm can sometimes be established by transthoracic echocardiography (",
"    <a class=\"graphic graphic_movie graphicRef50099 \" href=\"mobipreview.htm?24/40/25231\">",
"     movie 6",
"    </a>",
"    ), but TEE is more sensitive since the interatrial septum is visualized more consistently (",
"    <a class=\"graphic graphic_movie graphicRef65962 \" href=\"mobipreview.htm?15/10/15524\">",
"     movie 7",
"    </a>",
"    ). In the review of 195 cases cited above, 47 percent were missed with transthoracic echocardiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence of atrial septal aneurysm varies with the method of identification and the population studied. Atrial septal aneurysms have been found in 1 percent of necropsies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/16\">",
"     16",
"    </a>",
"    ] and 0.2 to 2 percent of patients undergoing transthoracic echocardiography (TTE) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. With transesophageal echocardiography (TEE), atrial septal aneurysms were detected in 2.2 percent of population controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/19\">",
"     19",
"    </a>",
"    ], 4 percent of patients referred for TEE for a reason other than detection of a source of embolic stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/12\">",
"     12",
"    </a>",
"    ], 4.9 percent of patients undergoing cardiac surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is an increased prevalence of atrial septal aneurysms among patients with cerebral ischemic events [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/12,19,21\">",
"     12,19,21",
"    </a>",
"    ]. As an example, atrial septal aneurysm was observed in 7.9 to 15 percent of patients with a possible embolic stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/12,19\">",
"     12,19",
"    </a>",
"    ], and 28 percent of those with a cerebral ischemic event and normal carotid arteries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/21\">",
"     21",
"    </a>",
"    ]. Two mechanisms have been proposed to explain the association between atrial septal aneurysm and cryptogenic stroke. Since atrial septal aneurysm is commonly associated with PFO and atrial septal defect, paradoxical embolism may occur via the septal defect. In patients with atrial septal aneurysm without an intracardiac shunt, it has been hypothesized that fibrin-platelet particles adhere to the left atrial side of the aneurysm and are dislodged by oscillations of the aneurysm, causing systemic embolism.",
"   </p>",
"   <p>",
"    An intracardiac shunt has been reported in up to 78 percent of patients with an atrial septal aneurysm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/12-15,19,21\">",
"     12-15,19,21",
"    </a>",
"    ]. Most patients (54 to 84 percent) with cerebral ischemic events and an atrial septal aneurysm also have an interatrial shunt, usually via a PFO [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/3,15,19,21\">",
"     3,15,19,21",
"    </a>",
"    ]. In a multicenter review of 195 cases in which atrial septal aneurysm was detected by transesophageal echocardiography (TEE), atrial septal aneurysm was the only defect in 32 percent and was associated with an interatrial shunt in 54 percent, most often a PFO (33 percent) or atrial septal defect (19 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/15\">",
"     15",
"    </a>",
"    ]. Some atrial septal aneurysms are associated with multiple atrial septal defects (perforations) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Left-sided sources",
"    </span>",
"    &nbsp;&mdash;&nbsp;A common source of cerebral emboli originating in the systemic arterial circulation in patients with atrial septal abnormalities is the left atrium, especially in those with atrial fibrillation. Patients with an atrial septal defect are at risk for atrial fibrillation. Although evidence is more limited, patients with PFO or atrial septal aneurysm may also be predisposed to atrial fibrillation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/17,23\">",
"     17,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another potential source of embolus is a left-sided prosthetic valve. Infective endocarditis can lead to embolic events and should be considered as a potential cause in any patient with a susceptible substrate (eg, prosthetic valve). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/52/18249?source=see_link&amp;anchor=H7#H7\">",
"     \"Complications and outcome of infective endocarditis\", section on 'Embolization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Older patients are also at risk for atherothrombotic and lacunar cerebrovascular events. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/17/40216?source=see_link\">",
"     \"Clinical diagnosis of stroke subtypes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     RISK OF EMBOLIC STROKE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 30 to 40 percent of ischemic strokes are cryptogenic (ie, without an identified cardioembolic or large vessel source and with a distribution that is not consistent with small vessel disease). The causes of cryptogenic stroke are likely heterogeneous with embolism a dominant etiology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/10/40105?source=see_link\">",
"     \"Cryptogenic stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is an increased prevalence of patent foramen ovale (PFO) and atrial septal aneurysm in patients who have experienced a cryptogenic stroke, suggesting that paradoxical embolism",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other mechanisms related to PFO and atrial septal aneurysm are the cause of some proportion of cryptogenic strokes. However, the detection of an atrial septal abnormality in a patient with an embolic stroke does not prove a cause-and-effect relationship. As an example, in a report of 134 patients with cerebral embolic events, an atrial septal aneurysm was found in 45 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/24\">",
"     24",
"    </a>",
"    ]. However, 41 of these 45 patients had other potential sources for embolization.",
"   </p>",
"   <p>",
"    Furthermore, accumulating data suggest that the presence of an isolated PFO is",
"    <strong>",
"     not",
"    </strong>",
"    associated with an increased risk of recurrent ischemic stroke. In addition, there are conflicting data pertaining to the combination of PFO and atrial septal aneurysm and an increased risk of recurrent ischemic stroke.",
"   </p>",
"   <p>",
"    The evidence regarding these issues is reviewed in the sections that follow.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Case-control studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of case-control studies have reported an increased prevalence of PFO",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    atrial septal aneurysm in patients who have had a cryptogenic stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/12,13,15,19,25-27\">",
"     12,13,15,19,25-27",
"    </a>",
"    ]. A meta-analysis of case-control studies published in 2000 found that the presence of a PFO, atrial septal aneurysm, or both was significantly associated with an ischemic stroke in patients &lt;55 years old (odds ratio [OR] 3.1, 6.1, and 15.6, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/28\">",
"     28",
"    </a>",
"    ]. In comparison, the association in those &ge;55 years old was less certain (OR 1.3, 3.4, and 5.1, respectively).",
"   </p>",
"   <p>",
"    A subsequent prospective case-control study examined 503 consecutive patients with ischemic stroke using TEE, and compared 227 patients who had cryptogenic stroke (classified before TEE was performed) with 276 control patients who had stroke of known cause [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/29\">",
"     29",
"    </a>",
"    ]. In multivariate analysis, the presence of a PFO was independently associated with cryptogenic stroke both in patients &lt;55 years old (odds ratio [OR] 3.7, 95% CI 1.42-9.65) and in patients &ge;55 years old (OR 3.0, 95% CI 1.73-5.23).",
"   </p>",
"   <p>",
"    Even in a patient with a cryptogenic stroke, the presence of an atrial septal abnormality does not establish the stroke etiology. A 2009 meta-analysis of case-control studies evaluating the prevalence of PFO in patients with cryptogenic stroke suggested that approximately one-third of PFOs detected in such patients are incidental findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with PFO, some retrospective analyses have identified certain risk factors that may increase the likelihood of initial and recurrent stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/31\">",
"     31",
"    </a>",
"    ]. These include a history of Valsalva maneuver (eg, straining) preceding the cerebral embolic event, a history of multiple strokes, and possibly a hypercoagulable state [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/11,32-34\">",
"     11,32-34",
"    </a>",
"    ]. In contrast, one study found that these factors were not associated with radiologic markers of stroke recurrence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The association of an atrial septal defect with cerebral embolic events has been less well studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/4,15\">",
"     4,15",
"    </a>",
"    ]. In one series of 103 patients (mean age 52 years) with a presumed paradoxical embolism and an atrial septal abnormality undergoing percutaneous closure, a PFO alone was present in 81, an atrial septal defect alone in 12, and both a PFO and atrial septal defect in 10 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     PFO characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;PFO characteristics associated with increased risk of recurrent stroke include large PFO, large right-to-left shunt, spontaneous right-to-left shunt, greater PFO flap mobility, prominent Eustachian valve or Chiari network, and the presence of an atrial septal aneurysm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/31,36-41\">",
"     31,36-41",
"    </a>",
"    ]. However, characteristics such as shunt size or concurrent atrial septal aneurysm were not associated with increased recurrent stroke risk in some studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/42-47\">",
"     42-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conflicting evidence on the risk of recurrent stroke in patients with concurrent PFO and atrial septal aneurysm is discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Prospective and therapeutic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prospective studies of the risk of cryptogenic stroke with PFO and atrial septal aneurysm have yielded variable results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/3,20,29,38,42-44\">",
"     3,20,29,38,42-44",
"    </a>",
"    ]. However, there is good evidence that PFO alone is not associated with an increased risk of recurrent stroke.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis identified four observational studies that evaluated patients with a PFO and a prior cryptogenic ischemic stroke or TIA and compared them to a non-PFO group [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/48\">",
"       48",
"      </a>",
"      ]. The three largest studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/38,43,44\">",
"       38,43,44",
"      </a>",
"      ] were prospective. The pooled relative risk of recurrent ischemic stroke associated with PFO was 0.8 (95% CI 0.5-1.3) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The French PFO-ASA study evaluated 581 patients with a cryptogenic stroke who were younger than age 55 (mean age 42 years): 216 (37 percent) had a PFO, 10 (1.7 percent) had an atrial septal aneurysm, and 51 (8.8 percent) had both [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/3\">",
"       3",
"      </a>",
"      ]. The patients with cryptogenic stroke and PFO were younger and significantly less likely to have traditional risk factors for stroke (hypertension, hypercholesterolemia, smoking) than those without PFO. This observation is compatible with another report in which the prevalence of PFO was 10 percent in a control group of 100 patients; among those with an ischemic stroke before the age of 50, the prevalence of PFO was 21 percent in 19 patients with an identifiable cause of stroke and 54 percent in 26 patients with no identifiable cause [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/26\">",
"       26",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      All patients in the French study received",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      (300",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      for secondary prevention of stroke, except for patients who also had a deep vein thrombosis or pulmonary embolism, who received three to six months of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/43\">",
"       43",
"      </a>",
"      ]. After four years, there were no stroke recurrences among the 10 patients with an atrial septal aneurysm alone, and an isolated PFO, regardless of size, was not a significant predictor of recurrent stroke. In comparison, the presence of both atrial septal aneurysm and PFO was a significant predictor of an increased risk of recurrent stroke (15.2 versus 4.2 percent at four years in the absence of these abnormalities, hazard ratio 4.2, 95% CI 1.5-11.8).",
"     </li>",
"     <li>",
"      The cryptogenic stroke segment of the PICSS study (which was included in the meta-analysis cited above) prospectively followed 630 patients with ischemic stroke, including 265 (42 percent) with a cryptogenic stroke [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/44\">",
"       44",
"      </a>",
"      ]. The average patient age was older than in the French PFO-ASA study (59 versus 42 years), and patients were randomly assigned to receive either",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      (325",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      (mean INR 2.04). On transesophageal echocardiogram, the patients with cryptogenic stroke had a higher incidence of PFO than those with a known cause of stroke (39 versus 29 percent) and a significantly higher incidence of a large PFO (20 versus 9.7 percent). The overall incidence of atrial septal aneurysm was 11.5 percent; the incidence of atrial septal aneurysm in patients with a PFO was not given.",
"      <br/>",
"      <br/>",
"      Among all patients in PICSS, no association was found between the presence of PFO alone and recurrent stroke or death and, in contrast to the PFO-ASA study, there was also no association in patients with a PFO and an atrial septal aneurysm. Among those patients with cryptogenic stroke, the two-year risk of recurrent stroke or death was not significantly different between those with PFO (14.3 percent) and those without PFO (12.5 percent). There was, moreover, no evidence of reduction in risk among those cryptogenic stroke patients with PFO assigned to the warfarin group (hazard ratio 0.52, 95% CI 0.16-1.67).In addition to being older on average, patients in PICSS had higher rates of hypertension, diabetes, and prior stroke than patients in the French PFO-ASA study, making typical stroke etiologies such as atherosclerosis and heart disease more likely, and PFO or atrial septal aneurysm less likely, to be the proximate cause of stroke. The observation that patients in PICSS had markedly higher rates of stroke recurrence (approximately 15 percent at two years) is compatible with this hypothesis.",
"     </li>",
"     <li>",
"      The CODICIA study evaluated 486 adults with cryptogenic stroke using contrast transcranial Doppler to quantify the magnitude of right-to-left shunt (RLSh) during Valsalva maneuver [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/42\">",
"       42",
"      </a>",
"      ]. Over a mean follow-up of two years, stroke recurrence was low overall (28 patients [5.8 percent]) and similar in patients with massive RLSh (n = 200), nonmassive RLSh (n = 97), and no RLSh (n = 189). There was no association between massive RLSh and recurrent stroke, or massive RLSh with concurrent atrial septal aneurysm and recurrent stroke. This was true for the entire study group and for the subgroup of patients &lt;55 years old.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Population-based studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two prospective population-based cohort studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/45,46\">",
"     45,46",
"    </a>",
"    ] and one population-based case-control study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/47\">",
"     47",
"    </a>",
"    ] suggest that PFO and large PFO are not independent risk factors for ischemic stroke.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The NOMAS study prospectively evaluated 1100 stroke-free subjects 40 years of age or older (mean age 69 years) from Manhattan using transthoracic echocardiography to detect PFO and atrial septal aneurysm [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/45\">",
"       45",
"      </a>",
"      ]. The following observations were reported:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      PFO was detected in 14.9 percent of subjects, and atrial septal aneurysm in 2.5 percent. At a mean follow-up of 80 months, an ischemic stroke occurred in 68 subjects.",
"     </li>",
"     <li>",
"      PFO was associated with a statistically nonsignificant minor increase in stroke risk (hazard ratio [HR] 1.64, 95% CI 0.87-3.09), as was the coexistence of PFO and atrial septal aneurysm (HR 1.25, 95% CI 0.17-9.24).",
"     </li>",
"     <li>",
"      Isolated atrial septal aneurysm was associated with a statistically nonsignificant increase in stroke risk (HR 3.66, 95% CI 0.88-15.3), possibly due to small numbers of patients with this finding.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The SPARC study prospectively evaluated 588 randomly sampled subjects 45 years of age or older from Olmsted County, Minnesota using TEE [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/46\">",
"       46",
"      </a>",
"      ]. The findings were as follows [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/46\">",
"       46",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      PFO was present in 24.3 percent of subjects, and atrial septal aneurysm in 1.9 percent. At a mean follow-up of 5.1 years, cerebrovascular events (transient ischemic attack, cerebral infarct, or death related to cerebral infarct) occurred in 41 patients.",
"     </li>",
"     <li>",
"      PFO was not a significant independent predictor of cerebrovascular events after adjustment for age and comorbid conditions (HR 1.46; 95% CI 0.74-2.88). Furthermore, there was no association of large PFO size with risk of cerebrovascular events.",
"     </li>",
"     <li>",
"      Atrial septal aneurysm was associated with a nearly four-fold increase in the risk of cerebrovascular events, but this risk did not achieve statistical significance (HR 3.72; 95% CI 0.88-15.71), possibly because atrial septal aneurysm was present in only 11 subjects, of whom only two had cerebrovascular events.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A population-based, case-control study evaluated 1072 residents of Olmsted County, Minnesota who had TEE and included 519 randomly selected controls without cerebrovascular ischemic event (stroke or TIA), 262 controls without stroke or TIA referred for TEE because of cardiac disease, 158 cases with non-cryptogenic ischemic stroke or TIA, and 133 cases with cryptogenic stroke or TIA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/47\">",
"       47",
"      </a>",
"      ]. PFO and large PFO were not independent risk factors for cryptogenic stroke in the entire study population, which was generally older than age 65.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The small number of patients younger than age 55 led to wide confidence intervals in the analysis of that subgroup, and the study does not refute the contention that PFO is associated with an increased ischemic stroke risk in children or young adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/49\">",
"     49",
"    </a>",
"    ]. A larger population-based study focusing on this age group is needed to determine whether PFO is an independent risk factor for cryptogenic stroke in those younger than 55 years.",
"   </p>",
"   <p>",
"    The authors of all three population-based studies pointed out the discrepancy between their findings of no statistically significant PFO associated stroke risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/45-47\">",
"     45-47",
"    </a>",
"    ] compared with the highly variable and often elevated PFO-associated stroke risk in previous studies. They speculated that methodologic weaknesses of earlier studies, including overdetection of PFO in referred cases of cryptogenic stroke, and underdiagnosis of PFO in patients with known causes of stroke, led to an overestimation of hazard ratios for cryptogenic stroke associated with PFO.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Conclusions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The true risk of primary or recurrent ischemic stroke associated with PFO and atrial septal aneurysm is difficult to estimate. However, available data can be summarized as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Multiple case-control trials have found an association between cryptogenic stroke and the presence of a PFO. However, approximately one-third of PFOs detected in patients with cryptogenic stroke are likely to be incidental findings. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Case-control studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prospective studies have found that the presence of PFO alone is",
"      <strong>",
"       not",
"      </strong>",
"      associated with an increased risk of recurrent stroke in subjects with cryptogenic stroke. The presence of PFO together with an atrial septal aneurysm was a significant predictor of an increased risk of recurrent stroke in the PFO-ASA study [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/3\">",
"       3",
"      </a>",
"      ] but not the PICSS or CODICIA studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/42,44\">",
"       42,44",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Prospective and therapeutic studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Population-based cohort studies have found no statistically significant association between the risk of first ischemic stroke and presence of a PFO. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Population-based studies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The 2011",
"    <span class=\"nowrap\">",
"     AHA/ASA",
"    </span>",
"    guidelines noted that the presence of PFO, with or without an atrial septal aneurysm, is of uncertain importance for the development of a first or recurrent cryptogenic stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/50\">",
"     50",
"    </a>",
"    ]. Similarly, the earlier 2004 AAN practice parameter on recurrent stroke with PFO and atrial septal aneurysm concluded that PFO alone is not associated with a meaningfully increased risk of recurrent stroke or death in patients who have already had a cryptogenic stroke, although a small increase or decrease in risk cannot be excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/51\">",
"     51",
"    </a>",
"    ]. With conflicting evidence available from the PFO-ASA study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/3\">",
"     3",
"    </a>",
"    ] and PICSS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/44\">",
"     44",
"    </a>",
"    ], the AAN practice parameter also noted that the combination of PFO and atrial septal aneurysm possibly confers an increased risk for subsequent stroke in medically treated patients younger than age 55 compared with other patients who have cryptogenic stroke but no atrial abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/51\">",
"     51",
"    </a>",
"    ]. However, with the later publication of the CODICIA study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/42\">",
"     42",
"    </a>",
"    ], there are now two prospective reports suggesting that PFO plus atrial septal aneurysm does",
"    <strong>",
"     not",
"    </strong>",
"    confer an increased risk of recurrent stroke, whereas only one supports such a relationship.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;When a patient is evaluated for a cryptogenic stroke or transient ischemic attack (TIA), the assessment should determine whether the event is clinically suggestive of an embolic stroke. Embolism is especially likely when neuroimaging reveals infarcts in multiple vascular territories or a single wedge-shaped infarct involving cortex and the underlying subcortical white matter. With embolic stroke, the neurologic deficit is typically maximal from the onset, with a tendency to improve quickly. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/47/28410?source=see_link&amp;anchor=H18#H18\">",
"     \"Overview of the evaluation of stroke\", section on 'Determining a presumptive diagnosis of stroke subtype'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A patent foramen ovale (PFO) or atrial septal defect should be considered in any patient with a cryptogenic embolic stroke. The history should include specific questions that define the circumstances immediately preceding the event. Was the patient straining, coughing vigorously, or engaged in strenuous isometric effort such as lifting or pushing a heavy object? Was there any risk for deep venous thrombosis such as prolonged immobility (eg, sitting in a cramped airline seat with legs dependent and knees flexed) or hypercoagulability?",
"   </p>",
"   <p>",
"    Other identifiable causes of stroke should be excluded by appropriate evaluation and testing. Vascular imaging, including magnetic resonance angiography, CT angiography, or Doppler and color duplex ultrasonography of the extracranial and intracranial arteries, is useful to evaluate for large vessel occlusive disease.",
"   </p>",
"   <p>",
"    All patients with suspected embolic stroke should have a transthoracic echocardiogram. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/47/28410?source=see_link&amp;anchor=H28#H28\">",
"     \"Overview of the evaluation of stroke\", section on 'Confirming the diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Echocardiography is also the diagnostic test of choice for the detection of a PFO, an atrial septal defect, or an atrial septal aneurysm. Echocardiography with agitated saline contrast is used to detect transient right-to-left shunting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/48/5896?source=see_link\">",
"     \"Identification and assessment of atrial septal defects in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/32/3593?source=see_link\">",
"     \"Patent foramen ovale\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with an embolic-appearing stroke without an alternative explanation (ie, cryptogenic), we suggest TEE when transthoracic echocardiography is nondiagnostic. The TEE should be performed with color Doppler study and agitated saline contrast injection at rest, with cough, and Valsalva maneuver. Although agitated saline contrast is not routinely injected via a femoral vein site in most centers, sensitivity for detection of a PFO is higher when contrast is injected from a femoral vein site as compared to an antecubital site [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/52\">",
"     52",
"    </a>",
"    ]. When a satisfactory Valsalva maneuver cannot be accomplished in a sedated patient undergoing TEE, positive end-inspiratory pressure can produce the desired stimulus.",
"   </p>",
"   <p>",
"    Transcranial Doppler (TCD) ultrasound with agitated saline contrast is also a sensitive method of detecting right-to-left shunt [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/53\">",
"     53",
"    </a>",
"    ]. However, unlike TEE, transcranial Doppler cannot detect other cardiac sources of embolism, and it does not differentiate between intracardiac and extracardiac sources of shunting. Thus, transcranial Doppler is complementary to TEE for PFO detection during a work-up for stroke etiology. In addition, transcranial Doppler is a sensitive, minimally invasive method for follow-up, if PFO closure is attempted. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/63/14328?source=see_link\">",
"     \"Treatment of atrial septal abnormalities (PFO, ASD, and ASA) for prevention of stroke in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Source of the embolus",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with a PFO",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    atrial septal aneurysm and an embolic event, clinical evaluation should include evaluation for the potential source of embolic material, although thromboses in the proximal lower extremity or pelvic veins is found in a minority of cases. Studies using x-ray venography or magnetic resonance venography to examine patients with ischemic cerebral events or other suspected embolic events have found low rates of proximal leg or pelvic deep venous thrombosis in such patients (10 to 22 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/54-56\">",
"     54-56",
"    </a>",
"    ]. Among those with documented deep vein thrombus, most had no symptoms or signs of venous thrombosis.",
"   </p>",
"   <p>",
"    Identification of a venous thromboembolic source in patients with PFO and cryptogenic stroke provides additional evidence of a causal relationship between the PFO and the ischemic event. Identification of deep venous thrombosis also has implications for therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/63/14328?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment of atrial septal abnormalities (PFO, ASD, and ASA) for prevention of stroke in adults\", section on 'Recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are four potential explanations for the relatively low rates of proximal deep vein thrombosis associated with cryptogenic stroke and PFO:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The emboli consist of platelet fibrin particles that normally circulate in the systemic venous bed and are too small to be seen with conventional testing. These particles are removed by the efficient lytic system of the lungs; however, when shunted across a PFO or ostium secundum atrial septal defect, they may lodge unlysed in the cerebral circulation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The clot forms in the heart at the edges or in the tunnel of the PFO or in an atrial septal aneurysm.",
"     </li>",
"     <li>",
"      The embolic source is in the systemic arterial circulation (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Left-sided sources'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Deep vein thrombi have resolved (lysed, completely embolized or recanalized) during the delay between onset of the embolic event and venography.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Proximal deep vein thrombi may also be missed because some patients with cryptogenic stroke had received intravenous lytic therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/48/39689/abstract/56\">",
"     56",
"    </a>",
"    ]. Also, evaluation for deep vein thrombosis was incomplete in these studies since venography evaluated either the lower extremities or pelvic veins but not both.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic options for secondary prevention of embolic stroke in patients with an atrial septal abnormality, including patent foramen ovale (PFO), atrial septal defect, and atrial septal aneurysm, include medical therapy with antiplatelet agents or anticoagulation, and surgical or percutaneous closure of the defect. These options are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/63/14328?source=see_link\">",
"     \"Treatment of atrial septal abnormalities (PFO, ASD, and ASA) for prevention of stroke in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/1/12306?source=see_link\">",
"       \"Patient information: Patent foramen ovale (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H119934741\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Emboli leading to stroke or to transient ischemic attack can originate in either the systemic venous circulation (paradoxical emboli) or in the systemic arterial circulation. Some patients with cryptogenic stroke have a patent foramen ovale (PFO), an atrial septal defect, or an atrial septal aneurysm that can be identified by echocardiography. These structures have been implicated in the pathogenesis of embolic events. However, identification of one or more of these atrial septal abnormalities in a patient with an ischemic event does not prove a causal relationship since other sources or conduits of embolism may also be present. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Sources of emboli'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Approximately 30 to 40 percent of ischemic strokes are cryptogenic (ie, without an identified cardioembolic or large vessel source and with a distribution that is not consistent with small vessel disease). The causes of cryptogenic stroke are likely heterogeneous, with embolism a dominant etiology. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Risk of embolic stroke'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/10/40105?source=see_link\">",
"       \"Cryptogenic stroke\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There is an increased prevalence of PFO and atrial septal aneurysm in patients who have experienced a cryptogenic stroke, suggesting that paradoxical embolism",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      other mechanisms related to PFO and atrial septal aneurysm are the cause of some proportion of cryptogenic strokes. However, accumulating data suggest that the presence of an isolated PFO is",
"      <strong>",
"       not",
"      </strong>",
"      associated with an increased risk of recurrent ischemic stroke. In addition, there are conflicting data pertaining to the combination of PFO and atrial septal aneurysm and an increased risk of recurrent ischemic stroke. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Risk of embolic stroke'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The true risk of primary or recurrent ischemic stroke associated with PFO and atrial septal aneurysm is difficult to estimate. However, available data can be summarized as follows (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Conclusions'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Multiple case-control trials have found an association between cryptogenic stroke and the presence of a PFO. However, approximately one-third of PFOs detected in patients with cryptogenic stroke are likely to be incidental findings.",
"     </li>",
"     <li>",
"      Prospective studies have found that the presence of PFO alone is not associated with an increased risk of recurrent stroke in subjects with cryptogenic stroke. The presence of PFO together with an atrial septal aneurysm was a significant predictor of an increased risk of recurrent stroke in the PFO-ASA study but not the PICSS or CODICIA studies.",
"     </li>",
"     <li>",
"      Population-based cohort studies have found no statistically significant association between the risk of first ischemic stroke and presence of a PFO.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An atrial septal abnormality (PFO or atrial septal defect) should be considered in any patient with a cryptogenic embolic stroke. Other identifiable causes of stroke should be excluded by appropriate evaluation and testing. Vascular imaging, including MRA, CTA, or Doppler and color duplex ultrasonography of the extracranial and intracranial arteries, is useful to evaluate for large vessel occlusive disease. All patients with suspected embolic stroke should have a transthoracic echocardiogram. For patients with an embolic-appearing stroke without an alternative explanation (ie, cryptogenic), we suggest the use of transesophageal echocardiography (TEE) when transthoracic echocardiography is nondiagnostic. The TEE should be performed with color Doppler study and agitated saline contrast injection at rest, with cough, and Valsalva maneuver. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/1\">",
"      Cardiogenic brain embolism. Cerebral Embolism Task Force. Arch Neurol 1986; 43:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/2\">",
"      CORRIN B. PARADOXICAL EMBOLISM. Br Heart J 1964; 26:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/3\">",
"      Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke 2002; 33:706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/4\">",
"      Khositseth A, Cabalka AK, Sweeney JP, et al. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc 2004; 79:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/5\">",
"      Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001; 38:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/6\">",
"      Harvey JR, Teague SM, Anderson JL, et al. Clinically silent atrial septal defects with evidence for cerebral embolization. Ann Intern Med 1986; 105:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/7\">",
"      Caes FL, Van Belleghem YV, Missault LH, et al. Surgical treatment of impending paradoxical embolism through patent foramen ovale. Ann Thorac Surg 1995; 59:1559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/8\">",
"      Falk V, Walther T, Krankenberg H, Mohr FW. Trapped thrombus in a patent foramen ovale. Thorac Cardiovasc Surg 1997; 45:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/9\">",
"      Meacham RR 3rd, Headley AS, Bronze MS, et al. Impending paradoxical embolism. Arch Intern Med 1998; 158:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/10\">",
"      Langholz D, Louie EK, Konstadt SN, et al. Transesophageal echocardiographic demonstration of distinct mechanisms for right to left shunting across a patent foramen ovale in the absence of pulmonary hypertension. J Am Coll Cardiol 1991; 18:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/11\">",
"      Meissner I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 1999; 74:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/12\">",
"      Pearson AC, Nagelhout D, Castello R, et al. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol 1991; 18:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/13\">",
"      Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993; 24:1865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/14\">",
"      Belkin RN, Kisslo J. Atrial septal aneurysm: recognition and clinical relevance. Am Heart J 1990; 120:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/15\">",
"      M&uuml;gge A, Daniel WG, Angermann C, et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995; 91:2785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/16\">",
"      Silver MD, Dorsey JS. Aneurysms of the septum primum in adults. Arch Pathol Lab Med 1978; 102:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/17\">",
"      Hanley PC, Tajik AJ, Hynes JK, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 1985; 6:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/18\">",
"      Olivares-Reyes A, Chan S, Lazar EJ, et al. Atrial septal aneurysm: a new classification in two hundred five adults. J Am Soc Echocardiogr 1997; 10:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/19\">",
"      Agmon Y, Khandheria BK, Meissner I, et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999; 99:1942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/20\">",
"      Burger AJ, Sherman HB, Charlamb MJ. Low incidence of embolic strokes with atrial septal aneurysms: A prospective, long-term study. Am Heart J 2000; 139:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/21\">",
"      Mattioli AV, Aquilina M, Oldani A, et al. Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carotid arteries. A multicentre study. Eur Heart J 2001; 22:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/22\">",
"      Ewert P, Berger F, Vogel M, et al. Morphology of perforated atrial septal aneurysm suitable for closure by transcatheter device placement. Heart 2000; 84:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/23\">",
"      Djaiani G, Phillips-Bute B, Podgoreanu M, et al. The association of patent foramen ovale and atrial fibrillation after coronary artery bypass graft surgery. Anesth Analg 2004; 98:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/24\">",
"      Ilercil A, Meisner JS, Vijayaraman P, et al. Clinical significance of fossa ovalis membrane aneurysm in adults with cardioembolic cerebral ischemia. Am J Cardiol 1997; 80:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/25\">",
"      Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988; 2:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/26\">",
"      Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318:1148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/27\">",
"      Di Tullio M, Sacco RL, Gopal A, et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992; 117:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/28\">",
"      Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000; 55:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/29\">",
"      Handke M, Harloff A, Olschewski M, et al. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007; 357:2262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/30\">",
"      Alsheikh-Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke 2009; 40:2349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/31\">",
"      Wu LA, Malouf JF, Dearani JA, et al. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med 2004; 164:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/32\">",
"      Dearani JA, Ugurlu BS, Danielson GK, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999; 100:II171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/33\">",
"      Bogousslavsky J, Garazi S, Jeanrenaud X, et al. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996; 46:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/34\">",
"      Pezzini A, Grassi M, Zotto ED, et al. Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? Systematic review and meta-analysis. Thromb Haemost 2009; 101:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/35\">",
"      Kitsios GD, Lasker A, Singh J, Thaler DE. Recurrent stroke on imaging and presumed paradoxical embolism: a cross-sectional analysis. Neurology 2012; 78:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/36\">",
"      Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000; 109:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/37\">",
"      Homma S, Di Tullio MR, Sacco RL, et al. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994; 25:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/38\">",
"      De Castro S, Cartoni D, Fiorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000; 31:2407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/39\">",
"      Stone DA, Godard J, Corretti MC, et al. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996; 131:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/40\">",
"      Hanna JP, Sun JP, Furlan AJ, et al. Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention. Stroke 1994; 25:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/41\">",
"      Rigatelli G, Dell'avvocata F, Braggion G, et al. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study. Catheter Cardiovasc Interv 2008; 72:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/42\">",
"      Serena J, Marti-F&agrave;bregas J, Santamarina E, et al. Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study. Stroke 2008; 39:3131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/43\">",
"      Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345:1740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/44\">",
"      Homma S, Sacco RL, Di Tullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002; 105:2625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/45\">",
"      Di Tullio MR, Sacco RL, Sciacca RR, et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007; 49:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/46\">",
"      Meissner I, Khandheria BK, Heit JA, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 2006; 47:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/47\">",
"      Petty GW, Khandheria BK, Meissner I, et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc 2006; 81:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/48\">",
"      Almekhlafi MA, Wilton SB, Rabi DM, et al. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology 2009; 73:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/49\">",
"      Adams HP Jr. Cardiac disease and stroke: will history repeat itself? Mayo Clin Proc 2006; 81:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/50\">",
"      Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2011; 42:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/51\">",
"      Mess&eacute; SR, Silverman IE, Kizer JR, et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004; 62:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/52\">",
"      Hamann GF, Sch&auml;tzer-Klotz D, Fr&ouml;hlig G, et al. Femoral injection of echo contrast medium may increase the sensitivity of testing for a patent foramen ovale. Neurology 1998; 50:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/53\">",
"      Droste DW, Schmidt-Rimpler C, Wichter T, et al. Right-to-left-shunts detected by transesophageal echocardiography and transcranial Doppler sonography. Cerebrovasc Dis 2004; 17:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/54\">",
"      Lethen H, Flachskampf FA, Schneider R, et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack. Am J Cardiol 1997; 80:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/55\">",
"      St&ouml;llberger C, Slany J, Schuster I, et al. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 1993; 119:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/56\">",
"      Cramer SC, Rordorf G, Maki JH, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 2004; 35:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/48/39689/abstract/57\">",
"      Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 2003; 107:5.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1092 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-AEB5EC0217-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39689=[""].join("\n");
var outline_f38_48_39689=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H119934741\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SOURCES OF EMBOLI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Paradoxical emboli",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PFO and atrial septal defect",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Right-to-left shunting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Atrial septal aneurysm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Left-sided sources",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      RISK OF EMBOLIC STROKE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Case-control studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - PFO characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Prospective and therapeutic studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Population-based studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Conclusions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Source of the embolus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H119934741\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1092\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1092|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?12/48/13057\" title=\"movie 1\">",
"      TEE PFO",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?32/20/33094\" title=\"movie 2\">",
"      TEE PFO with contrast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?6/56/7040\" title=\"movie 3\">",
"      TTE two ASDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?40/32/41487\" title=\"movie 4\">",
"      TTE with color Doppler post-ASD repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?22/39/23167\" title=\"movie 5\">",
"      TEE ASD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?24/40/25231\" title=\"movie 6\">",
"      TEE IAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?15/10/15524\" title=\"movie 7\">",
"      TTE 4Ch IAS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/17/40216?source=related_link\">",
"      Clinical diagnosis of stroke subtypes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/52/18249?source=related_link\">",
"      Complications and outcome of infective endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/10/40105?source=related_link\">",
"      Cryptogenic stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/4/12361?source=related_link\">",
"      Echocardiography in detection of intracardiac sources of embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/48/5896?source=related_link\">",
"      Identification and assessment of atrial septal defects in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/47/28410?source=related_link\">",
"      Overview of the evaluation of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/32/3593?source=related_link\">",
"      Patent foramen ovale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/27/16825?source=related_link\">",
"      Pathophysiology and clinical features of atrial septal defects in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?12/1/12306?source=related_link\">",
"      Patient information: Patent foramen ovale (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/63/14328?source=related_link\">",
"      Treatment of atrial septal abnormalities (PFO, ASD, and ASA) for prevention of stroke in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_48_39690="12 lead ECG uncommon AVNRT";
var content_f38_48_39690=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81639&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81639&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1277px;\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    12 lead ECG of an uncommon form of an atrioventricular nodal reentrant tachycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The 12 lead ECG shows a regular, narrow complex tachycardia at a rate of 130 beats per minute. The QRS complexes are normal. There is an abnormal \"notching\" within the ST segment, representing a retrograde P wave (*). The interval from the proceeding R wave (RP interval) is longer than the PR interval; this is a \"long RP tachycardia\", due to an atypical atrioventricular nodal reentrant tachycardia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Martin Burke, DO.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39690=[""].join("\n");
var outline_f38_48_39690=null;
var title_f38_48_39691="Conflict resolution";
var content_f38_48_39691=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81769&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Six steps to conflict resolution for adolescents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       1. Keep your temper; stay calm.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\">",
"       Anger increases the heart rate and initiates a \"fight-or-flight\" response.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       2. Understand what triggers fighting.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       3. Understand that sometimes people use fighting to make themselves feel better.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\">",
"       Remember that the other person is upset and wants to use fighting to solve the problem.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\">",
"       The provocation is a response to their need, not to an irrevocable circumstance.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\">",
"       Don't get manipulated into fighting because they want you to fight to solve their problem.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       4. Understand that the other person is a decent human being.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       5. Talk to the decent side of the other person instead of matching insults.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       \"This isn't worth fighting about.\"",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       \"I have nothing against you. I don't want to fight you about this.\"",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\">",
"       \"If I have done something wrong, you can talk with me and I will apologize and try to fix it.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\">",
"       \"If I haven't done anything wrong, I'll tell you that, but I don't want to settle this by fighting.\"",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"1\">",
"       6. If these steps do not work, walk away from the situation. Try to use humor as you leave.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Stringham P. Pediatr Clin North Am 1998; 45:439.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39691=[""].join("\n");
var outline_f38_48_39691=null;
var title_f38_48_39692="Infant HIV prophylaxis regimen";
var content_f38_48_39692=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F85990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F85990&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Infant antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_left\" colspan=\"3\">",
"        <span class=\"subtitle1_left\">",
"        </span>",
"        <span class=\"subtitle1_left\">",
"        </span>",
"        <span class=\"subtitle1_left\">",
"        </span>",
"        <span class=\"subtitle1_single\">",
"        </span>",
"        For all HIV-exposed infants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle2\">",
"        Dosing",
"       </td>",
"       <td class=\"subtitle2\">",
"        Duration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        Zidovudine (ZDV)",
"       </td>",
"       <td>",
"        <p>",
"         Dose based on gestational age at birth&nbsp;and weight, initiated as soon after birth as possible and preferably within 6 to 12 hours of delivery",
"        </p>",
"        <ul>",
"         <li>",
"          <span class=\"sublist3_start\">",
"           <strong>",
"            &ge;35 weeks gestation at birth:",
"           </strong>",
"           4 mg/kg/dose orally (or, if unable to tolerate oral agents, 3 mg/kg/dose IV) every 12 hours",
"          </span>",
"         </li>",
"         <li>",
"          <span class=\"sublist3_start\">",
"          </span>",
"          <span class=\"sublist3_start\">",
"           <strong>",
"            &ge;30 to &lt;35 weeks gestation at birth:",
"           </strong>",
"           2 mg/kg/dose orally (or 1.5 mg/kg/dose IV) every 12 hours, advanced to 3 mg/kg/dose orally (or 2.3 mg/kg/dose IV) every 12 hours at age 15 days",
"          </span>",
"         </li>",
"         <li>",
"          <span class=\"sublist3_start\">",
"           <strong>",
"            &lt;30 weeks gestation at birth:",
"           </strong>",
"           2 mg/kg/dose orally (or 1.5 mg/kg/dose IV) every 12 hours, advanced to 3 mg/kg/dose orally (or 2.3 mg/kg/dose IV) every 12 hours after age&nbsp;four weeks",
"          </span>",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        Birth through&nbsp;six weeks",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1_left\" colspan=\"3\">",
"        Additional prophylaxis for HIV-exposed infants of women who received no antepartum antiretroviral prophylaxis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Nevirapine, in addition to ZDV as shown above",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Dose based on birth weight, initiated as soon after birth as possible",
"        </p>",
"        <ul>",
"         <li>",
"          <span class=\"sublist3_start\">",
"           <span class=\"sublist3_start\">",
"           </span>",
"           <strong>",
"            Birth weight 1.5 to 2 kg:",
"           </strong>",
"           8 mg/dose orally",
"          </span>",
"         </li>",
"         <li>",
"          <span class=\"sublist3_start\">",
"           <span class=\"sublist3_start\">",
"           </span>",
"           <strong>",
"            Birth weight &gt;2 kg:",
"           </strong>",
"           12 mg/dose orally",
"          </span>",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        Three&nbsp;doses in the first week of life",
"        <ul>",
"         <li>",
"          First&nbsp;dose within 48 hours of birth (birth to 48 hrs)",
"         </li>",
"         <li>",
"          Second&nbsp;dose 48 hours after&nbsp;first",
"         </li>",
"         <li>",
"          Third&nbsp;dose 96 hours after second",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States, July 31, 2012.",
"     <a href=\"file://www.aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf\">",
"      file://www.aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39692=[""].join("\n");
var outline_f38_48_39692=null;
var title_f38_48_39693="ICD in NSVT in MADIT";
var content_f38_48_39693=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F76854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F76854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 493px\">",
"   <div class=\"ttl\">",
"    Implantable defibrillator versus conventional drug therapy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 473px; height: 327px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Kaplan-Meier cumulative survival curves in the MADIT trial showing that selected high-risk patients (prior infarction, left ventricular ejection fraction &le;35 percent, nonsustained ventricular tachycardia, and an inducible sustained ventricular tachyarrhythmia not supressible with procainamide) have a better survival rate with an implantable defibrillator compared to conventional therapy with antiarrhythmic drugs (p = 0.009). The number of patients at each time period is noted at the bottom.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Moss, AJ, Hall, WJ, Cannom, DS, et al for the Multicenter Automatic Defibrillator Implantation Trial Investigators, N Engl J Med 1996; 335:1933.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39693=[""].join("\n");
var outline_f38_48_39693=null;
var title_f38_48_39694="Targets for antithrombotic therapy";
var content_f38_48_39694=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80270&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80270&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Targets for antithrombics",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 396px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AT: antithrombin; GP: glycoprotein; LMWH: low molecular weight heparin.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Authors/Task Force Members, Hamm CW, Bassand JP, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32:2999, by permission of Oxford University Press. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39694=[""].join("\n");
var outline_f38_48_39694=null;
var title_f38_48_39695="AV nodal physiology";
var content_f38_48_39695=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75699&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75699&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 481px\">",
"   <div class=\"ttl\">",
"    Physiology of the AV node in AF",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 461px; height: 184px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAC4Ac0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDE8Z+Ibfwp4avNavIZZre22bkixuO51QYyQOrCsqx+IGjut8usl9FuLK5W1nivmQbXZS64ZWKkFVJznsav8Aj/w5/wAJd4Sv9E+1fZPtXl/vvL8zbtkV/u5Gc7cde9ULzwHpnlaVHpKpYJZarHqkmEMjTsisMMzNnJ3dSTjHSvSw6wToJVr87b26Kyt5a6rZvrot8J+15/d2/wCH/wCAaA8ZeHmvbW0GrWxnuljeJQTgiQZjycYBYcgEgnPFOh8XaDNqw0yLU4GvjM9uIuf9an3kzjG4YPGc1h6v4A/tDXLy5XVGi06+ure8u7TyAzPJDjbtkzlVO1cjB9iKydA8B6lcareTa5cCDTYvEF1qtvZpGpeYsSI5DKGOFwx+XAPrW0cPl8oOftGnbbztttrrp268yvpLnWTty/19/wDXY6yLxx4alN35esWxFrGZZWyduwHaWBxhgDxlc1VHxE8Nya7p2lW18tzLfhvKmhw0WQ20KWz1J4GAeh6Vy0fwhWLS7nTo9WhMDW8ltBK9jmaNWIPzP5mGxjsq5rsNS8MTXHiDQNWtNQW3k0yN4HjaDzBNG23cB8w2n5evPXpTnSy2MrQm5LXytpp9nq/uEpV2tUlt/wAHqRweO9FTQtP1HVL22tBeIzoiSGYbVJBYFV+6O7YAFXj4t0L+1ItOXUoXu5CgVIwXGXAKAsAVBIIIyeciuLX4TLFpmjQQ6sjXOn2slm7z2heKeN3L8xiQEEE/3uauWfw1a18RadqcOrLbpaeRuS0tjA8wjjCBHIfaUOOhQnHGaqdDLHzONR/ato+/u9O39IFOvpePb/gnXa94l0fQGiXV7+K2aUFkVgSSo6tgA4UZGSeBWTbeNrW98df8I3YQrOY4BPNc+aAqgqWUKMHf/Dzkfe703xf4Ol1zUvt9hqf2C5ksZdNnLW4mV4JCCQAWG1sjg8/Q1P4a8JRaBrNxeW100kD2NtYxwunKLCpUEtnkkH0HSuaEcFGg5Sbc2nprZO6t07Xe7v1tsW3Vc7La/wCBH4k8c6boHibStEvI52nvyv71ANkAZtqFyTwC2QPoaivfH+nWMXiU3VvcxzaFIiSwkDdN5mPLKc87s8VleJvhhF4ivNcvL3WbtLq/MYgMQKpbrGBsBXd8+Gy2cjk9qs6v8PE1bxZpGuXepNvto4hewJDhL14juRj83y4bnHzcAD3rphDLOWHPJ3trvvo9NOusfJ2exDde7svT+vuZ0+ra/p2i2Vvc61dR2CzkKolP8eM7eOp4NUn8b+G00q11E6tAbO6LLC6hmLlfvfKBu478cd6n8R6B/bV/odz9p8n+zLwXe3y93mfIy7c5GPvZzz0rl1+HE1s0U+na0IL+O4vJFle0EieXcnLIU3jkYGGz9Qelc1CngpQTqzal17ddNn5a677FzlVT91af8N5+pq+LfiBonh7SmuvtMV5cNbfa4LeFsmWPs24AhQexPBrQbxdocep2+mz6jDHqExRRCSTh3GVQtjAY9gSCa4+++FRGny2Oka01pbXOmxadcia1E7OIySHU7l2nk5HI+lW5fhpH/wAJE+pQX8RhlniuZYLi180iRAoyjbwFztHUNjtXT7HLORL2jvrrZ+Vull17+q2I5q9/hPRKKKK8Q6gooooAKKKKACiiigAqlreqWmi6PeanqMohs7SJppnPZVGT9T6DvV2vKv2lXdfhoY1Zgkt/bpIoPDLv3YPqMqD+FTOXLFy7G2GouvWhSTtzNL73Y43VP2gdSlvHOieH7eOxHCG/mPmv7lU4X6ZNTaP+0FcpKF13w4Hiz/rNPucuB/uSAA/9914lRXgf2lXvfQ/Xf9Scs9nyWlfvfX/L8D7B8F/EPw34xzHo9+ovVGXsrgeVOo9dh+8Pdcj3rra+DpIkkZGYEPG25HUlWRuxVhyD7ivTvA/xl8QeHfLtteEmvaYON7MBeRD2Y8S/RsH/AGjXfQzKFTSej/A+QzbgrFYS9TCv2ke32l8uvy18j6jorA8HeLtE8YacbzQb1LhUIEsRBWWFv7roeVP6HtkVv16Sdz4xxcXZ7hWF438TWnhDw1d6zfxTTxQbVWCABpJnZgqog7kkjit2uQ+IXgv/AITR9EhudUuLLT9PvPtssNsCsk8iqRFiQEbNrHd0OcDpjNAjIb4w+F4fD3hbWLqS5htfEDtHB8gJhKZ3+Zg8BSNpxk5I4rQ1v4l+HLKHU0sdU0681LTn23Fo1yIjHidIW3HB24aQDpyeB7cvZ/By40uwt7XR/EzxLY60dY083Nn5/kbkKtE37wbwSd2crzng5rUvvhcLrwX4p8P/ANr7P7c1p9X+0fZc+TuuI5vL27/m/wBXt3ZHXOOMUAdPJ438OxeI10GXU449VeTyVhdHUNJt3BA5G0tjnGc1X8G+NLTxD4CTxVcx/wBnWIW4eUSPvESQyOjMSAOMRlulcnqXwkuL/wAeQ+Ip/ERljh1eLVY4Z7MySxhFx5Cy+YAsfcAJx33Vu6L8P/7M+Et54J/tPzftFre2323yNu37Q0rbtm452+Z03c47Z4ALMvxM8HJpy3667bTWZkeLzbdXmUMiq7A7AcYV0JJ4Geajsfid4XvfFzeHre/DXIskvkuOPIkjZDINr57IN5yAMHr2rH8W/C+417QvDmmQ68beDSbM2ckUtqZYLn92qCQxiRcOu3KklgM9Kr6R8Izp7QwnXTLYS+H18P38P2Ta9xGFcCSN9/7s5fOMN060Adr4Y8ZeH/FE1xFoOqQ3ksCq8iKGU7W+64DAblOOGGQfWsCP4naddfECTwrptuLi4t5hb3E8l3DCBJjcyxxsweUqPvbV4qH4afDZvBd+1zLqNrfFbMWUbpYmGXYGBG9zI27p0AUck4rPufg/BN44GtDV2TTv7YTXjZC1XzPtSrjifdkRk8lNvPrQBLoPxl0fVb60E2n3tlpWoRXk2nahKUMd0trnziFUllwASMjkDt0q/wCA/idaeLNYg05tJvtMmvNPGq2JuWRhcW2/Zu+Una2cHaecHNYfh/4K22m3enxXutS3uiaVDfQaZZC3EbwLd5Eu+Xcd/DED5VrT+HvwwfwrrlpqV/rjao+n6YNIsEFqIBFBv3/OQzb36DPyjA6UAX/+FnaHbeNta8OavKmnzWE9tbxTSuStw00QcdBhMbguWOCa1bfx54YuNdXRodZtn1Jp5LUQjP8Aro87484xuGDxnJ7VyXiT4U3OueJPEF1J4gWLRddubK4vrBbHMrC2VAqrMX+XJTJOzPb3Ob4T+GuszeIL278Q3a2ulW3iu812zsI4UZ52Zj5UrTBzhcMfk2g+tAHVSfF3wFH527xPYZiQyMAWJwG2nAA5IPUDJA5xjmu1s7mC9tILq0lSa2nRZYpUOVdGGQwPcEHNeV6b8HfsWmaVaf27v+w6fqdjv+x43/bHZt+N/GzdjHO7HUV6L4T0j/hH/CujaN5/2j+zrKGz87Zs8zy0CbtuTjOM4ycetAGrRRRQAUUUUAFFFFABRRRQAUUUUAUxqunnVW0sX9odTWPzjaCZfOCf3tmc498YrL8Q+KrLQ9Z0fTrqOZ5dSkKB4wCsI3IgZ+eAZJI0GOcuPQ1Rj+HugR/EaXxusM/9uyQiFm80+X90Ju2+u0BfT2zzUXijwHb+I77U7y8v7qO4ntI7W0MEkka2pQs6uVVwsp8xg2GGPkUepIBZXxlD/bklhLp90lut+NMF3uQoZzEJANu7dgg4zjr145rS1fxLpGkXYttRvBDNsWRl2MwRGYqHcgEIm4Y3NgDuap6J4RsdP1rUdXuY7a61K6ujcpOYAGhzEkZVSSSPunkY4bH1x/FPhXUte8S6rGs8Nrouo6PHp11I0XmPIpkm3omHGw7H+8VYfNx0oA2NH8YafqGsXWluWgvYruW0jVlYrK0a7jh8bd23LbM7sAnpzUi+MdDMM0hupUMRjBiktZUlfzCRHsjKh3DEEAqDnBx0NUJPBha4hlXUnjMer3GqgxxYYebbTQbAc8FfN3bsH7uMc5GHZfDGS3S5aW90meea3t7dmbS3w5iZ281z5+9pTv8Av7gQQPpQB17eLNFSS2je8KtOEZd0Mg8sOxVfMO393uYFRv25IIHNL4h1x9LubK0s7GS/v7sSPHAkip8kagsxJ+qgD1YdBkjk7b4Z+RPFNJqNtqErRRR3DalaNcljGzEGMmUFeGwN5k+6p5OS3U+I9Eu9QvbC/wBKv4rHULNZY0kmt/PQpIAGBXcvOVQg5/h6HNAEv/CRWb+FbfxBDl7G4giuYyxCkpIFK5ycDhh3qXTde07U72e1sZ2lkhLBmETiMlW2ttcja+1uDtJweDWfdeFIW8CW/hi0uGht7e2gtY5WXeQsW3GRkZOEqDw94Ul0nxLeap9uiEFwsg+x2sDwxMzyB/MkUyMpkGCNyqmd7k5yMAGpJ4j0uPU5tPNyzXMIPmBIXdUITftLhSofb823O7HOKov4w09pLBLQSyNcXy2MiSxvBJAxieUMyOoYAhOMgZznNVbnwpqJGuW2n62LOw1V5ZmCWx+0QyPGEJSUOMAMA2NueoDDjGTZ/DRI5ZHnvLNElu47mSKxsTboQsEsJAzIxyRJuLEk5HvwAdCnjTRpjbNb3BkgnlMYmZGjTb5MsvmKWA8xCsL4KbgevQGr1z4k0e2hllnv4UjihhuHYk/LHMzLE30ZlYD6Vz3/AAhd7dWGjWOq6xDcWulsfK8my8p3Q2k9sQx8xhuInDZAAymNvPFe38A3jQXK6hrME0kttptorQ2RiCrZzvKCQZGyW8zHUYxnnpQB0Nh4u0S+vYLS2vGNxNI0Ko8EkZEigsY23KNr7VLbWwxAyBjmptb8TaRokwi1S9WCTy/OI2M2yMHBkbaDtQHqxwB3IrN/4RH/AImP2r7b/wAxn+19vlf9O/k+Xnd/wLd+GO9Hizwj/wAJB/bP+nfZ/wC0dGm0j/Vb/L8zP7z7wzjP3eM+tAFxfFuitbSzLdufLmFuYhBJ5rSFd6hY9u98r8wKggqCRwCapaz470ews7ea1lN887QbEgR2AWWURBnYKQnJbhsZKkdapeI/AKaxq8+pfbIlna4huIo57YyxApE8RV1DqWBDkjBUggdRkGqPh5PHBLBaalY2ttctbSXUUOnkKXhm80GL978gboQd/rnJOQDopvFul21tJcXrywwxzTws6wvKqCFtru7ICEUdy2AO+OaZF4z0Z7vWbeSWaJ9KnS3mZ4WKuzJE6+WRncT5yqFHzE9ARgnmtd+GcmqW17b/ANqwNBdG9LRXVkZ44zcSFw6L5igSJkgOc+wXnNzUPh+14mpRHUovs93dW9+iSWpfZcQxQxfN84DRssIyuAcsSGHGADT1vx1o2maBNqaSvclYJ5kt44ZDI3lD5wyhS0eDhWLABSRnFdJazfaLWGYDaJED49MjNcDcfDyc2V1HY6hp1jNeWdxY3PkaawiaOXHzKnm5VwR1LMDnp0x31pD9ntYYd27y0VM4xnAxQBLRRRQAVxXxm0Vte+Gmu20Kb7mGH7XAAOTJERIAPrt2/jXa0EZGD0pNXVmVCbhJTjuj4PjdZI1dDlWAIPtTq1PFmif8I14t1nRAu2KzuWEAxj9y2Hix9EZR9QazfLfYH2NsJ27scZ9M18nVpunNwfQ/oTA4uOMw1PER2kk/+B8htFSeTL5hTy33gZK7TkfhUdZnWmmT6ZfX2j6pDqejXk1jqMXCTxHkj+6wPDL/ALJBFfRvws+MFr4lnh0fxFHFp2uv8sTqf3F2f9gnlX/2D+BPOPmunLZyXqyJFBJN5amVvLUkoq878jpjrntXbhcZOg7brt/kfM59w1hs0i6i9yp/N3/xd/XdfgfdlFeBfCH4vuslvoHjW5y7ERWmqyHiT0Sc9m6AP0bvg8t77X0FOpGrHmg9D8exuCrYGs6GIjaS/q67oKKKK0OUKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArnPEyLda54dsbk4s5Lh5mQ9JZI0LRofXnMmPWIe9dHWD4outLieyi1kbYlZ7xJvNMZhMK7y+QQ3TOcdQSDwSKAPNb7xNfaha6vYXuordzxXVrJmzeGS2iX7fGoUMmJEbbgFJck4Yg4BrRTxZr9wL0abewXWrfZr+WXTDGn+gSQviFWx8wD42ndndu3LgDFdpF428PyzJEl+d7SJFhoJFALkCMklcBXLAK5wrHgEmnv4y0BHu1k1KNBapcPK7IyoBASJgHI2koQdwBJHXGKAOb8I+LdX1zxPbWssccen3ME2qwOI8FrIlEtwT2diXc+wA+rvFWu+IbPVvEraTLE9vpGnQ3Edp9lMjSySCYZLA52rsDbQMnGM810us+JbTTbmC3BWaZruG1lUPt8nzASrH2wM02Hxfok9g15FdyNbhkVD9mlzMX+55S7cyhsEgoGBAOKAPOrrxlq8GjtOfEWky2kdwSZ7e/tWuXTyidgZkWAsG524BK988nRXxnfzeIDDBqaCdb3T4YdJkhRJp4J44Wmd1OXUoJHfggDYQc9vRItZ06XRm1ZbyIacqNI87naqKud27P3SCCCDgggg9KwofEXhnT3utRWaWCW/lLz+ZbziRjHGilzGy7lRUMeWwFAIJPOaAOKi8ca0dGNzBqMFzeSab9qvIDChGlXXnQoICFweRJKMOScwk5wcCTxD4s1nRv7Vt59aTydM1GSBpibaK7uE+yW86hBIoiYhp2BUbWIC4OcmvQ38U6Kuppp/25GumdI8KjMgZ1DIC4G1SwIK5Iz2zWcnjvSJNaNkkp+zLayXL3jI6xfLKkeFJXDgl/vKSOMUAc3p/i3WbvxuLSS6srSAXaQjT7uRIZZYGiDCRYyvmFyxzkNtABUjIJq34y1C6svGkwOrva2r6FO8No7AJcTIzE7c87gCCdvIA9K66+8RaVZLcGe7G6C4W0eONGkk85kWQRqigszbGVsAHjnsayYfHmj3E+ow2xuGeykgRzJGY1bzfL2kM2Bx5qgg4Oc4FAHF2vjDVor42o1Sz82TT2e0iDxyQ27LZiUPdr/r0G8Md4JQqUHDMKu+HPHcnm6d/aOpg2DXk1rcXly9uYmcQJIixzRYjYZLY4DZBBGRz2p8XaErXwbUY0FlFNNM7KyoEiOJWViMOEPDbSdp4ODV7R9ZsNYFx/Z8xkNu4jlVo2jZSQGBwwBwQQQ3Qg8E0AeUWHjvxDexeHpZbzTrF7jS9OvQt1KkCXrzKDNtDKWbHQLGQVJGchgK7FJv7Lk8UW9pqMWn2kN1BMk0kXmpBJLsMkYXI+8SGxngzZ9BWrB4v0l5UhkmZZ3nmhEcaNNt8udoCzlAQil0IyxAzkdQQItWbw7oUKWuoBgLq5N+I9stxI8kbq5lONzbUby+T8q/IOBgUAdNRXM/8ACZabDNqMd+zWxtLx7RVVWlaXbFHIzhUBIUCQZPQYySK0Y/EWjySxxpqNszyzJbxgOPnkeLzVVfXKfMMdRQBq0VX0+9t9RsLa9sZlntLiNZYZU+66MMqw9iCDVigAooooAKKKKACiiigDwr9pbwlvtbbxfYx/vLUC21AKPvQE/JIfUoxwf9lyf4aoTXHh1vAk3g5dZsTPDYJdI2V8v7YCZG2zbtrZDBMex+le/XtrBfWc9peRJNbTxtFLG4yrowwQfYgkV8e/EfwXc+A/Eh09jJLpNxmTTrl+SyDrEx/vp+owfUDzcbTcL1YK91Z+h9pwxjI4lwy+vUceV80Nvi7a/Oy63aO41rxFpcvhGXxLFewN4m1HTk0ma3DAyKwJEkzDqNyKAD7iub8F3Gi2XhyS5v7XSru//tOCJY705IgIO9gu4cD1OQM1wtFeQ8Q3JSa/rufo1PJ4U6MqMZOzd/RLaOnRLQ9isLXwZHfXsanRGsV1K5W7a5my62u3939nOctznlcnOO1JoU+hWPhW4bTp9Hijn0C7jmeaZFvXu2DDZtJztwBgAYNePUVSxNtoowlkbkrSrSe2/lf8dfwXY9Q8aW/hJ/Bc6aRb6XKphtzbyC4jFwGJAkWSPO9s5bORgdqn+Efxbl8OeToni2d5tE4S31CQ7nsx0CSd2j9G6r3yOV8opCAQQQCDwQaqnjZU580Vp2McXw1QxeGdCtJuV21J7rb71pqtE99HqfdsbpLGskbK6MAyspyCD0INOr5a+DnxPfwbLDoniCZpPDLttguGOTp5PY+sP/oH+70+o43SWNZI2V0YBlZTkEHoQa+go1o1o80T8gzHLq+XV3QrqzX3Nd15DqKKK1OEKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACua8ZeF/wDhJFjH2z7Nstbq2/1W/PnxGPd1H3c5x39q6WigDkL/AMF/a2vz9v2fak09P9Tnb9llMmfvc7s49vesG28AX2r6RqNj4gu0t7OS51k20EMI8xFu5rgCRpN5Dfu5iQoVcbsHkV6bRQBxA8F3txfS3up6vbzXUt5bXbeRZGNP3KMoUKZGPO7OST9KzE+GJ+y7JNStwYbiG5tbWO0cWULJHLG37hpmwGWZgQjIBtQgAg59KooA5g+FI5PA8/h55Le3EqyfvbK38lEdnL7ljLN/EckEnJznrVe/8Na1eXMV6+t2KaisE9m0iac3lGCXyyQEMxIcNHkNuI+YgqeMdfRQBxdv4DitYnhtr5lg+22F1GrR7iq2qRIEJ3clhF97tnocVnJ8OJ/7NisJNZja2tNKbSrLFmQ0aB4mjaQ+Yd5HlKDgLu56V6LRQBxEfgzUFvJtSOsWx1dtV/tNJRYnyVJs0tTGY/NyRtQnIcEEjqAcuuvBt7dvqnn6vAU1GW0upwtmQRNA0Ryp8zhGWLG0gkE53HGD2tFAHnt/8Opb7SL3S5dXQWJsr60sgLU74PtQILSNv/ebAxAACZHUk811unaR9j13V9S8/f8A2h5P7vZjy/LUr1zznPoK1aKAPP5fh7KZYHt9Vit3jvbi7NzFbOlyBLeSXJjWRZQNv7zYQ6upxnAyRWv468Ky+JorZbe8gsZoVkVbryHaeLeF+aKRJEKH5f8AaB4yDiupooA4seDLy11qfV9L1iOHUJJZ2D3Fp5qiOaO3VlKh1y262jYNkdxis27+Ftq0Cx2Goy2xg0q30+1Yx7/JmgI8u4PI3MAiKRxkAjPNejUUAV9Ps4dP0+2srVdlvbRLDGvoqgAD8hViiigAooooAKKKKACiiigArnvHfhSw8Z+HLjSdTBUPh4Z0HzwSj7si+49O4yDwa6Gihq+g4ycWpRdmj4d1vSb/AMP61d6NrMYjv7U4bb92VT92RPVWHT05B5BqnX1X8Y/h8njbRUmsPKh1+yBa0mfhZAfvROf7revY4PqD8qOk0FzcWt5BLa3ts5int5Rh4nHY/wBD0IwRXzuNwjoy5o/C/wAD9l4Y4hjmdL2NZ/vY7/3l3X6mtofh3WNeEp0fTbm8WL77RISF9iemfasyaKSCaSKZGjljYo6MMFSDggjsa7nRtS0fUfAMWg6hq7aNcW1812JDA8qXAKgc7OQwxxnj39Og0HxF4Zs/Cd1YXOqm5aaC7R47q3kLNIxby2XapXng5ZiwPoKxjRhJL3rad191j0KuZYilKX7pytKySUtv5uazTv2VrbN3PJfLcxGQI3lghS2OAT0GfXg/lQsbsjOqMUXG5gOBnpk12Fn4i0eHwRcabLolpJeNcwvzLP8AvNscimUkPgMCw4GAdx4OODQPEWj2PhTUbG70S0uLmRoSN8s4+0bWYkttcBduRjGM+9ZqnHT3lsdcsXWSk1Rk7SS6ap2136f11txhAIIIBB4INex/AD4g/wBlXNv4Q1qU/YZm26XO5/1TH/l3J9D/AAf98/3a8dpksayxlHzg+hwR7g9jWmFxDoT5lt1OXPMmp5thnSlpJaxfZ/5PqfeNFeV/Ajx/J4p0d9I1ibfr+moN8jdbqHOFl+v8Le/P8QFeqV9NCanFSjsz8OxGHqYarKjVVpRdmFFFFUYhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAFMarp51VtLF/aHU1j842gmXzgn97ZnOPfGKwfEHjKHRdVvbWbT7qa3sbWC8u7mJk2xRzSSop2lgzYMLkgAnHTJ4qOP4e6BH8RpfG6wz/27JCIWbzT5f3Qm7b67QF9PbPNW7jwlp954vuNe1CGC7drW2t4YpoQ3ktDJM+8EnkkzDtwUBzzwATSeLNFia8FxeNbfZInnla4hkhXy0IDupZQHUEgFlyBkeopIfF2iTPaiK7do7pgkU4gk8lmZiir5u3YCWGACeTjGciuQb4XSSPdtPq8Dyz6dd6ebn7CftEgmkicSTSGQ+Yy+Vjoo+Y4C9K1fEngWTWvESai+oQeUt1ZXSJPaGaSA28qSFIX3gRq+zB+UnLE5I4oA3LTxXot2R5F7lWlSFJGidI5WZiq7HICuCwIBUkZ78imX/jDQrAkXGoLuBmBWON5D+5KiU4UE4Quu49B36GuWu/Al3aaF4iW1uEuJru2xZ2VkhtYo7hWLxzAPI6q4fYcqFHy/dPAGrB4HWK30+Nb47rbSb3TpXaLJmkuXheScnI53xMxHcv1GOQDUXxhoLQ3Eo1BfLgaNGJjcbvMJEZQY+dXIIVlyGIOCaJfF+ixafFfPdS/ZH8zMi20rCLyztk83C/utp4bftxznpXNa/4K1BBbT6Rcxy3SrpFriSH5Y1tLiR2lI3jcCJT8oIPy8E54h1n4ZzapZXEM+r20r3aXX2oXFiZYfMmYHzYo/NARlACgsXOAO+SQDY1L4g6VZz6hCsdw8lhqFvYT5jIXMoiO9CAdwAmXjqSDgYwTpyeL9EjsILxrxjFMZAqrBI0g8s7ZC0YXcoQ8MWACnrisk+CZhd3LJqcYtJ9Qs9SaM2xLiWBIEwH342stuvG3IJJyelU774cJPcrdJeWslys97JtvLMzQlLiUSFSgkU7lKgBg2CM5HIwAbP8AwnGkvf31nCZZJbS4tbdmwBG/ntEEZHztI/fJxnJ7A8VqaZr2napdzW9hO0zxbgWETiNtrbW2uRtfDcHaTg8GubbwLIGnih1G3isprjTrtoUs8FZLSSBgEIfARlgC7cEqWzk4wdjwnod7oFrHYNqEFzpduhjto/sxSVF3ZAeTeQ+BxkKuep5oAS48YaRaGYXs5idJpoVREaZ38rbvIVATgBgTxwOTUs/izQ4LuC2fUEMswiZdis6gSnERZgCqhzwCSATwKzIPBflazJf/AG/O975/L8np9p8rvu/h8r8c9sc1IPAHlaY9n/aWd1rpltv8j/nzffnG7+Ppj+H3oA3X8XaHG96smoIi2cUs00joyx7Iv9aVcja+zo20naeDilt/Fug3Npd3UGpwPb2kayzSAnCozMqt05BKMARnOOK5KT4Xx/2ZrGnw3dikF7a3ltFO1gWuYRcKwOZPMwwXeeAqkgAE9Sej8R+Eota8Q6TqbXTwpaEC5gVARdqrrLErHtslRWHXqw75oANZ8baNpNnq09y90W022nu5IhbOjSpD9/yi4VZMHAJU4BIyRnNSnxfpSvP5kzqkawlf3bGSVpC4VViA3lv3bcbee3Q1ys/wv+1y6gb3VYpBd2N/YtOtni5ZLnHMkpkO8oBgAKo9hWtceDr+41hdZk1e2GrxvbyRutkwhDxpcRnMfm5IZLlhjcMEA57UAat34z8P2lrBczainkzxPOjJG7/u0OHchQSqqT8xOAvfFb4IYAggg8giuH/4QHNncRHUsyXOn6hZyv5HBlu5vOeUDdwAxbCZ6EDPFdpaQ/Z7WGHdu8tFTOMZwMUAS0UUUAFFFFABRRRQAUUUUAFeY/GL4YQ+Mrb+09I8q18S26bY5W4S5Qc+VL7ejdVPtkV6dRUyiprllsa0a1ShUVWk7SWqaPhF0mgubi1vIJbW9tnMU9vKMPE47H+h6EYIor6g+MXwwh8ZW39p6R5Vr4lt02xytwlyg58qX29G6qfbIr5fdJoLm4tbyCW1vbZzFPbyjDxOOx/oehGCK+exmDdB3Xwn7Jw5xHTzWn7OppVW67+a/VdAooorhPqAooooAtaPqt9oOs2WsaQ4S/s33xgn5ZF/ijb/AGWHB9OD1Ar7N8I6/Z+KfDdhrWnE/ZruMOFb7yN0ZG91YFT7iviivWv2cfFTaX4kn8M3TE2WqFri1yf9XcKuXX6Mi7vqh/vV62WYi0vZS2ex+f8AG+TqpTWYUl70dJea6P5benofSlFFFe2flwUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV52+qS6Lo2oeJmdWVNZmGqkruIs45ZIFxjlRGgjkOOuHPVq9EqpaadbWl5eXVvGyTXjrJP87FWZVChtucA4ABIAzgZzgUAeT67441zT4bF5rpLPUvJhvZLG5aKFJI5p2xEqlGkldEAVtpQAjJJzirFz4z1cXlytrqMcmoldUB0nykZrY24fyDgDflgqsSSQ275QBXrdZdvoNhBq76mq3El424K091LKse4gt5aOxWPOB90DpigDz3UfHdzeLfvo+taWtlAlgxuBPEn+sExkWOR8xh/kXAfjqOuK6C98R3Y+Fseu2Mkgu3t4nSS6hUNlmVcsqnb3z8pweo4xXbUUAeUaz4p1zTZb3Tm1BfJttZNjJqs/lQlIzZQ3ChmKGJSXlKhiuCFA+8QasaXrPi7Wft4sdS0triy0uC4SO3iEsV3O4mAxLnhCY16A9eDjr6fRQB5LfeOtWv9MtNWsJVsND1K9MMF1PsgaGJIuSzyKyoXlDqCykYUAcsCOg0K5nm1XwzqE01nLf6jZTRXhsn3wzrHhllU9wrHAI4/fHrxXdVUGnWv9pyah5bG8eEQeYZGO1Ac4UZwuT1IAJwM5wMAGQl/cnwJcX9pqtjd3i2kskV/LEYrdnAba7KCSEBAzgngHFebyeK9QurLT76ykn1TULC6vfKDNDIlxIunSSKiPBhJF3HGcBgeCMjJ9jsbSCwsbezs4lhtbeNYoo16IijCgewAFT0AeVT+NNR0+2vb2w1GPxFpNi1nJJcxRoDKZvNjeBdmACreQ/TID4JPWoX8V+Jf7N1AX19p9jLptxBp91KWSDfMDI8hieUFAXjNsyh+AGYdSMet0UAcVd+JLsfDG11yzeUTTR2+6e5gXdDG8iJJOyKdp2IzScHaduRwa5/X/FtzYRziw8UwXEMNjJc2NyY4ZP7SuQSBbZUBWIwo2xhWO8YPynPqtFAHmdz4m12HWJZ1l8yJNYbTF01Y0wy/YjMPnxu378DIOMdj1GBYeKbmLUJ9ZTW4r92sdHa8ciMRWiyXxW4XCgbAkbOTvJZcZY8V7XRQB5cPGs1/fRxvrlrpejSXl7GuqoIyh8ryvKiDuCnziSRskciMgYzmq1trF5Ff6rHNrbXkv/CRWMcdrIdpSCT7Ph1UHcEO5sD7vXqc161RQB49F441o6MbmDUYLm8k037VeQGFCNKuvOhQQELg8iSUYck5hJzg4He+Dr29nuvEVhqF0142maiLWOd0VHdGtoJvmCgLkGZhwBwB3ya6SigAooooAKKKKACiiigAooooAK4D4nfDPTPG9v8AaVIsNdiTbDfIucjski/xp+o7Ed+/opSipKz2NKVWdGaqU3aS2aPh/wAQaNqfhrWH0rX7U2t6o3Lg5jmT+/G38S/qOhANUa+0fGPhTSPF+kNp2uWomizujkU7ZIX7OjdVb/8AUcivln4ieAdX8BXRa+JvdEdsQ6miYC+izAfcb3+63bB+UeHi8vcPfparsfqfD/GFPFWw+OfLPpLo/Xs/wflscpRQCCMjkUV5Z90FPtr240u9tNTsf+PuxmS6hGcbmQhtv0OCp9iaZRVQk4SUl0McRQhiKUqM9pJp/M+49Iv4NV0qy1GzbdbXcCXETeqOoYH8iKt15p+zvfyXnwusYZck2M01opz1RXJQfgpA/CvS6+tjLmSkup/PNak6NSVKW8W19wUUUVRkFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUVwsWv+L2+Lc+iP4ejXwgtqJE1XJ3NJtB65x94lduM8bs4rE+Jtxb2Wu3N3dXmnX22xTy9In1CWzugVZzvtSmd0j5CjAByqjcM4AB6rRXnGoeKddh1zUtIRBHLZxTao07wjabMxHyk9A/nEr7rCx71mTeIvEVtDeTPq5l+yadpmq7DbRgSNcyyo8JwMiMCHjHz5bliBigD1qivKP+E3vYtSu3Goi+NvealDc6XawxvLb20CTNHMFHzFy0caYY7W80YGRk458Warexuj+I4o7O01HT5W1G3uYZQsMwlVkldESPaGVeMEZOCzUAe30V5HbavrGj311c6fcPfpea5f2q2GxSshSzmnQqwG7cXhVeDtwx4zzWcfFGtX+hrcS+JbOOBLvTpZri1uI2ktg8+2VZVVVEcWCvyyZbhgxPYA9toryr/hJriPXbqzuNbi0rS3v7gNqjbCCyQWpjiDSZRd/myN05EZAwTmuu8RX0sMnhPypRKLrUUjeQZUOpt5mzgHuVBwcigDp6K8dsPGHiIeHNNu5dQjmudT0fTdQBa3QLbyTTxxuFAxldsnRiTkcEA4Eur+LddsLp9Nk1OKG2gvrm3fVrloYOUigeKNmZDGC3nSfwjIi4weaAPXaK8ztdZ8W6nFqk1leae09hYWtytpbQeYlzM8PmOqyE52MQQpxnnPtWfqnju9vNLh1Cx1D+z7XU5LiXS5ZjFbxtDCqLiR5EclpHLOqKuWXoQFJoA9corxb/AISXUbi11u/utVKS3Gm6bewaaW2qBIqb3jGd20MSDg4yea0bvxpq0A1SWG/hlvYU1Mz6YY0zp6QCTyJDj5sNsTO4kN5gK4FAHrFFcBY6zqUTa1a3+txRfZ4LG6jvZ7VSIzMzBo9i7cglMLnJG/ktiu/oAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACmzRpNE8UyLJE6lWRhkMD1BHcU6igDxjxx8CtMv2kvPCE6aNdsctaMC1pIfZRzH/wHj/ZrxnxL4I8UeGCzazotx9nX/l7tP9Igx6kqNyj/AH1Wvs2iuStgqVbVqz8j6DLOJsflyUIS5oLpLVfLqvk7HwbDPFOu6CRJF9UYGieaOCMvM6og7scV9na94G8L+IJ/P1jQdOurgnJnaECQ/Vxhv1qHRPh54R0PUI77S/D9hBeR/cm8vcye6ls7T7jmuL+ydfi09D6f/iID9n/A97/Fp+V/63OO/ZlvNOn+G8UdlqNtc3jXEs9zbxt89sWY4R1PIOAOcYJzjI5r1uvO/G3wp0nXtSGt6NcT+HfE6ZMeqad8jMf+mqDAkB75wT0zjisC3+IviPwJcR2HxY0wNYlhHF4k02MvbPnp5yAZjb6DBPQYGa9eMVFJI/PKtSVWcqk927v5nsdY/iPxHpvh3+y/7VmaL+0r6LTbbahbdPJnYpwOAdp5PFXtL1Gz1awgvtMuobuzmXdHNC4dHHsRXGfF/wAEXHjrT/DllDJAtvZa3bX92JJXiL26Bw6oyDIch+OV+opmZqx+ONIn1K4sLQ3Fxc22opplwqR7RFK6lgSWIyuB1XP0rat9X0251CaxttQs5r2H/W28c6tJH/vKDkfjXj2nfB3UNL1ffp89imnJ4ptdaijkuZpJBbxROjKWZSTJlxjJIx/FWh8MPhrrXhTxlPqNxPpsOkmOYLawO1wxeRw25WkjV4h6rvfPr3oA7y08Z6LceJ9V0BrpbfUdPlhhdJ2VBM8sYkUR5OWO0jPFbX2+z4/0u35m+zj94P8AW/3Ov3vbrXjvi/4V65rvjLxLdRf2HHpmt3enz/bXeQ3tolskYYRLs27mKEZ3jg/ko+GnilPEMYW60RtDj8XHxMrF5VuSG3boyNpXI3cc8+o6EA9cs9Y0y9ujbWeo2dxcBPMMUU6u+zON2Ac4965DxB8V/C+iz6pG9y94NOsF1Cd7LZMoQzeTtBDffDdR6Vweh/BK+0/R/CttHLpNle2emapY6leWYYSTNcoVidTsBfZkn5sY7Zqhc/BnxPeaLqNoy+GbGSbw5b6JELSWUI8kVwshlk/dDG4A56nOOvWgD3x9U09NSTTnvrVdQdd62pmUSsvqEznH4Vcrxab4TamPiVNrnm2F5Yy6zFq6yzXMkVxblduUCqhDgAELl1GDyDXtNABRRRQAUUUUAFFFFABRRRQAVl61r2naK0KahOySTBmRI4nlYquNzbUBIVdy5Y8DcMnkVqVy3jrwrL4mitlt7yCxmhWRVuvIdp4t4X5opEkQofl/2geMg4oAmt9W8PQeJ7uKK4UatdOttM5DlS8aF1i3n5FIVmYICDyzY6mpIfGGhTW088d+DFCEYkxODIrnajRgjMgY8KUyGPAya5u38F3+oapq6axcpHo0mqm9jhWP99P/AKMkYYyh8KN247dgOVHODgwRfC2JdLSzkutOLwCHyLhNOKu3lMCPO/ekSAgYIUJ1JGOMAGtdeKfDnhvw5eX+nl5Q/wBrvvs0ccrSPIpLS7lwWjw5wxYAKSAcdK29N8SabqF6LO3ldroD5wInKK20MU8zGwsAwJXOR6Vytx8PJzZXUdjqGnWM15Z3Fjc+RprCJo5cfMqeblXBHUswOenTGnpXg6Ww8UpqyX8UcKqweC2geE3BKBQZj5hR8YyDsDcDng5ANy61/TbXVU06a4P2whSUSJ3EYYkLvYAqm4g43EZwcVTh8Z+H5bOa7XUoxbw+Vud0dciV9kTLkDcrtwrLlSehqG58N3Lazqdxa6hFHYaqEF7bSWxd22p5Z8uQOuzKADlW5GRislPAdzLDbrqGsRzy2v2COB47QxgRWtyk+HG87nfywpYYA6heoIBt3HjHRotLW9W4kkDtIiQrbyGYvHnepj271245yox1NO0jxVpt/o1pfSTx25mjtGeJmyYnudoiQnHUs6gfWsiXwTcR6jLqFhqkcV3JLeZ821MieVc+UWXAdTuBhQhs+oxzVSL4e3MENnbW+sxLaR/2W06vZlnleykRwVbzAEDiMAghsdcnpQBs6t470PTbe6mea4nW2lWKQwW7spYyrEdrYCttdwGCkkcjGeKsP4t0qIz+dK6BJY4UVY2kklZ4hKAsagvnYSSMZABPSsk+DL7+wbjRE1iAaaJPOtAbImWJxcCdN7eZiRQRtwFUkHk55LpPB16NZk1m31a3j1ZrhZ9z2bND/wAeywOpj8wHB2hh8wI4GSM5ANWbxjoEUluh1KJvtEUM6NGrOvlysVjkZlBCozKQGJAz35rfrg4/h4kWn31rHqTYutPs7Eu0OSGgmmlaT738ZnPy8bcdTnA7ygAooooAgvbO3vokiu4hLGkscyqegdGDofwZQfqKnoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACo54YriCSG4jSWGRSjxuoZWB6gg9RUlFAHkep/Cu+8N6hNrHwm1UaHdOd82kXGX0+6PoU6xk+q9Og29aueGPi1bHVY9A8fafL4U8SHhY7ps21z23QzfdIPoT7Ak16hWT4n8OaP4p0qTTvEGn29/Zv/AATLnafVT1U+4INAGsDkZHSiquk6fbaTpdpp9hH5VpaxLBCmSdqKMAZPJ4FWqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACmu6xozuwVVGSScACnVW1Oxt9T027sL2MSWt1C8EyH+JGUqw/ImgCXz4sRnzUxJ9z5h8309akr5r8HeHvHJM9lPp9zHceBtNvbTQ7i4Qql9dSF1hkTcNrBYlCjqASM4o025+Ig8MakIbzxUbuVrEbJrCbzrd/OVZijyJhgVJJChkGM8CgD6UqC9vLawtZLq+uIba2jGXlmcIi845J4FfOfi7QfFJuTb3dx4u1DS9F8V2s9vcJE01x9laAl5U2pmTY5wCoONzcemt4gtPGl14J+It+t14jlvIdRlttJ01rYMskG6ArIieXvf+MAgleG4zk0Ae+1FdXEFpbyXF1NHBbxKXeWRgqoB1JJ4AryW5l8Qt8RdWj1WTxXGPtcS6Oumwk6e0GwZMzAbQd27dvII429q4PU9S8d6/4MttJvNI8UGdfD2owakLiwcLc3WAI8ED5ieduOueM84APpmN0ljWSNldGAZWU5BB6EGnV85+K7zxzaa/pkWh2fia2jsotNCCGGaa3uUIQTZVV2JtywYPluMjA6elfCi11+VtY1LxLqGstIdQu7e3sbtFSJIBMTG6jYGOV6MWIx0oA9CorxW4/4TFNF+IeryS+J7q4ttTuLbS9LgxCJLcmHEsR8su2AXwVJBAYKNxzXDXWn+MdW8OD+1/8AhK7m10vxRY3UDizmFz9m2gySRpIpkfYenUg9R2AB9R1DdXdtaBDdXEMAdgiGRwu5j0Az1NeExT+Pf+FnxfaLnX4bBdTgW3UWUsttNYEKCJCq+Wj4LFmchlPT0qb9ovwxfavqdpd6bZXOrXMul3OnxWR02S5iR5MYmWQEJDICR8znoO+MUAe33F5bW0sUdxcwxSSnbGsjhS59AD1qevl74heDdfV7m11PRdQ16/n8LWWnafdwW7XCw3kbr5hL/wDLIkgvvJAI79q9K+Nmh6pqHw70NI/7Tubywv7Ke6GnKZJWCsBI6qASxHLDA6jNAHq9NkkSJC8rqiDqzHAFeFzXHjf/AITaBbRvEzH+0rMWYkhIsm00xr5zTkqAJfvbgcOGxtFbH7UOlvrHwxubOx03VtQ1V5IzZxafDPKARIhcyLH8uNgbG8EZ6c4oA9Ymu7aBws9xDGxGcO4Bx+NNkvbWKeGCS5gSabmKNpAGf/dHU/hXjHxm8PW/xEn8LWFh4auTc6rIou9YudOeOSwso2LshZ1BjdiTtU4PX+8K5T4p+D9Xl8U+L7bT9Av7q81BNIj8N38Nu0kdisDDzQZukPQnkjOaAPpO5vLa1kgS5uIYXnfy4lkcKZGxnauepwDwPSp68s+OlndXMng2e3t9XlgtdYEtzJpVu800MfkyAsAisR1AzjvxzXnk2ueLbVfDOn67eeLIku7XVJEgs4WbUJY1dfsxlVVLBwCMnjH8R60AfS1FfOniMfE2bTY2kuvENvf2fhSC7KafFlJtRFwwKNhCGfZgsinn6V6P8L4/ENp4j8X2Gt3OrXmnxS2ktjcainLmSANMEYKoKh8jCjC9PWgD0SiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACq0thZy38F9LaW73sCskVw0amSNWxuCtjIBwMgdcVZooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The atrioventricular (AV) node modulates the response between the atrium and the ventricle. In atrial fibrillation, the atrial rate is up to 600 beats per minute while the ventricular rate in response is 90 to 170 beats per minute; this difference in the rate results from several properties of the AV node that impede impulse conduction. The AV node generates a slow action potential (AP) that is mediated by calcium (Ca++) ion currents; the node is therefore slow response tissue. Parasympathetic innervation via the vagus nerve also slows conduction, while activation of the sympathetic nervous system speeds conduction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_48_39695=[""].join("\n");
var outline_f38_48_39695=null;
